<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<Template name="NMVB Template" version="">
  <Description>Template for extracting data elements for NMVB domain</Description>
  <Options>
      <Option name="preferred.concept.code.pattern" value="\d+"/>
  </Options>
  <TemplateItems>
    <TemplateItem concept="NMVB:Tumor_Site" name="Tumor Site" type="finding" value.domain="self">
      <Filters>
        <Filter type="section">FINAL DIAGNOSIS:</Filter>
      </Filters>
    </TemplateItem>
    <TemplateItem concept="NMVB:Tumor_Dimension" name="Tumor Dimension" type="feature" value.domain="value">
      <Values>
        <TemplateItem concept="NMVB:3D_tumor_size" name="3D tumor size" type="numeric-value" value.domain="boolean"/>
      </Values>
    </TemplateItem>
    <TemplateItem concept="NMVB:Histological_Type" name="Histological Type" type="finding" value.domain="self">
      <Filters>
        <Filter type="section">FINAL DIAGNOSIS:</Filter>
      </Filters>
    </TemplateItem>
    <TemplateItem concept="NMVB:Histochemical_Special_Stain_Profile" name="Histochemical Special Stain Profile" type="finding" value.domain="self"/>
    <TemplateItem concept="NMVB:Tumor" name="Tumor" type="feature" value.domain="attribute">
      <AttributeValues>
        <Attribute>
          <TemplateItem concept="NMVB:Differentiation_or_Grade" name="Differentiation or Grade" type="attribute" value.domain="boolean"/>
        </Attribute>
        <Values>
          <TemplateItem concept="NMVB:High" name="High" type="value" value.domain="boolean"/>
          <TemplateItem concept="NMVB:Indeterminate" name="Indeterminate" type="value" value.domain="boolean"/>
          <TemplateItem concept="NMVB:Intermediate" name="Intermediate" type="value" value.domain="boolean"/>
          <TemplateItem concept="NMVB:Low" name="Low" type="value" value.domain="boolean"/>
        </Values>
      </AttributeValues>
      <AttributeValues>
        <Attribute>
          <TemplateItem concept="NMVB:Configuration" name="Configuration" type="attribute" value.domain="boolean"/>
        </Attribute>
        <Values>
          <TemplateItem concept="NMVB:Cystic" name="Cystic" type="value" value.domain="boolean"/>
          <TemplateItem concept="NMVB:Diffuse" name="Diffuse" type="value" value.domain="boolean"/>
          <TemplateItem concept="NMVB:Endophytic" name="Endophytic" type="value" value.domain="boolean"/>
          <TemplateItem concept="NMVB:Exophytic" name="Exophytic" type="value" value.domain="boolean"/>
          <TemplateItem concept="NMVB:Localized" name="Localized" type="value" value.domain="boolean"/>
          <TemplateItem concept="NMVB:Mixed" name="Mixed" type="value" value.domain="boolean"/>
          <TemplateItem concept="NMVB:Nodular" name="Nodular" type="value" value.domain="boolean"/>
          <TemplateItem concept="NMVB:Papillary" name="Papillary" type="value" value.domain="boolean"/>
        </Values>
      </AttributeValues>
      <Filters>
        <Filter type="section">FINAL DIAGNOSIS:</Filter>
      </Filters>
    </TemplateItem>
    <TemplateItem concept="NMVB:Additional_Pathologic_Findings" name="Additional Pathologic Findings" type="finding" value.domain="self"/>
    <TemplateItem concept="NMVB:Surgical_Margins" name="Surgical Margins" type="feature" value.domain="attribute">
      <Modifiers>
        <TemplateItem concept="NMVB:Positive_for_mesothelioma" name="involved" type="modifier" value.domain="boolean"/>
        <TemplateItem concept="NMVB:Negative_for_mesothelioma" name="negative" type="modifier" value.domain="boolean"/>
      </Modifiers>
	<Filters>
        <Filter type="section">FINAL DIAGNOSIS:</Filter>
    </Filters>
    </TemplateItem>
    <TemplateItem concept="NMVB:Immunohistochemical_Profile" name="Immunohistochemical Profile" type="finding" value.domain="self"/>
  </TemplateItems>
  <Terminology format="index finder tables" location="memory" name="NMVB" uri="http://edda.dbmi.pitt.edu/ontologies/NMVB.owl" version="null">
    <Description>Template for extracting data elements for NMVB domain</Description>
    <Sources>
      <Source code="NMVB" name="NMVB">Template for extracting data elements for NMVB domain</Source>
    </Sources>
    <Relations>
      <Source code="Broader" inverse="false" name="Broader"/>
      <Source code="Narrower" inverse="false" name="Narrower"/>
      <Source code="Similar" inverse="false" name="Similar"/>
    </Relations>
    <Languages>ENG</Languages>
    <Roots>NMVB:Template, NMVB:Terminology, NMVB:Slot</Roots>
    <Concepts>
      <Concept code="NMVB:LeuM1" name="LeuM1">
        <Source name="NMVB"/>
        <Term preferred="true">LeuM1</Term>
        <Relations>
          <Relation name="Broader">NMVB:Immunohistochemical_Profile</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:FISH" name="FISH (fluorescence in situ hybridization)">
        <Source name="NMVB"/>
        <Term preferred="true">FISH (fluorescence in situ hybridization)</Term>
        <Term>FISH</Term>
        <Term>fluorescence in situ hybridization</Term>
        <Relations>
          <Relation name="Broader">NMVB:Histochemical_Special_Stain_Profile</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Lung" name="Lung">
        <Definition>One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.</Definition>
        <Definition>Lobular organ which has as its parts alveoli connected to the tracheobronchial tree. Examples: There are only two instances, right lung and left lung.</Definition>
        <Definition>One of a pair of organs in the chest that supplies the body with oxygen, and removes carbon dioxide from the body.</Definition>
        <Definition>&lt;p&gt;When you breathe, your lungs take in oxygen from the air and deliver it to the bloodstream. The cells in your body need oxygen to work and grow. During a normal day, you breathe nearly 25,000 times. People with lung disease have difficulty breathing. Millions of people in the U.S. have lung disease. If all types of lung disease are lumped together, it is the number three killer in the United States.&lt;/p&gt;&lt;p&gt;The term lung disease refers to many disorders affecting the lungs, such as &lt;a href='http://www.nlm.nih.gov/medlineplus/asthma.html'&gt;asthma&lt;/a&gt;, &lt;a href='http://www.nlm.nih.gov/medlineplus/copdchronicobstructivepulmonarydisease.html'&gt;chronic obstructive pulmonary disease&lt;/a&gt;, infections like &lt;a href='http://www.nlm.nih.gov/medlineplus/flu.html'&gt;influenza&lt;/a&gt;, &lt;a href='http://www.nlm.nih.gov/medlineplus/pneumonia.html'&gt;pneumonia&lt;/a&gt; and &lt;a href='http://www.nlm.nih.gov/medlineplus/tuberculosis.html'&gt;tuberculosis&lt;/a&gt;, &lt;a href='http://www.nlm.nih.gov/medlineplus/lungcancer.html'&gt;lung cancer&lt;/a&gt;, and many other &lt;a href='http://www.nlm.nih.gov/medlineplus/breathingproblems.html'&gt;breathing problems&lt;/a&gt;. Some lung diseases can lead to &lt;a href='http://www.nlm.nih.gov/medlineplus/respiratoryfailure.html'&gt;respiratory failure&lt;/a&gt;.&lt;/p&gt;&lt;p &gt;Dept. of Health and Human Services Office on Women's Health&lt;/p&gt;</Definition>
        <Definition>either of the pair of organs occupying the lateral cavity of the thorax that effect the aeration of the blood.</Definition>
        <Definition>Lobular organ the parenchyma of which consists of air-filled alveoli which communicate with the tracheobronchial tree. Examples: There are only two instances, right lung and left lung.</Definition>
        <Definition>Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood.</Definition>
        <Definition>deviation from or interruption of the normal structure or function of the lung or lungs.</Definition>
        <Definition>Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. [MeSH]</Definition>
        <Definition>One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border. (NCI)</Definition>
        <Definition>Pathological processes involving any part of the LUNG.</Definition>
        <Definition>union of left lung and right lung</Definition>
        <Definition>A non-neoplastic or neoplastic disorder affecting the lung. Representative examples of non-neoplastic disorders include chronic obstructive pulmonary disease and pneumonia. Representative examples of neoplastic disorders include benign processes (e.g., respiratory papilloma) and malignant processes (e.g., lung carcinoma and metastatic cancer to the lung).</Definition>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <SemanticType code="T047" name="Disease or Syndrome"/>
        <SemanticType code="T191" name="Neoplastic Process"/>
        <Source name="NMVB"/>
        <Term preferred="true">Lung</Term>
        <Term>Lung Diseases [Disease/Finding]</Term>
        <Term>Lung disease</Term>
        <Term>Pulmonary Diseases</Term>
        <Term>Primary malignant neoplasm of lung</Term>
        <Term>Lung, NOS</Term>
        <Term>pulmonary</Term>
        <Term>PULMONARY DISORDERS</Term>
        <Term>lung</Term>
        <Term>Lung Diseases</Term>
        <Term>Lung structure (body structure)</Term>
        <Term>LUNG</Term>
        <Term>Lung Disorder</Term>
        <Term>DISORDER PULMONARY</Term>
        <Term>Entire lung</Term>
        <Term>Disorder lung</Term>
        <Term>Pulmonary disease</Term>
        <Term>LUNG DISORDER</Term>
        <Term>Respiratory System, Lung</Term>
        <Term>Entire lung (body structure)</Term>
        <Term>PULM DIS</Term>
        <Term>LUNG DIS</Term>
        <Term>Lung Disorders</Term>
        <Term>lung disorder</Term>
        <Term>Lung disease NOS</Term>
        <Term>Pulmonary Disorders</Term>
        <Term>Primary malignant neoplasm of lung (disorder)</Term>
        <Term>Pulmones</Term>
        <Term>Disease, Lung</Term>
        <Term>Lung structure</Term>
        <Term>PULMONARY DISORDER</Term>
        <Term>Pulmonary disorder</Term>
        <Term>Pneumopathy</Term>
        <Term>DIS PULM</Term>
        <Term>Pulmo</Term>
        <Term>Lung disorder NOS</Term>
        <Term>Diseases, Lung</Term>
        <Term>Disorder of lung (disorder)</Term>
        <Term>Pulmonary Disorder</Term>
        <Term>Lung disorder</Term>
        <Term>PULMONARY DISEASE</Term>
        <Term>lungs</Term>
        <Term>Disorder pulmonary</Term>
        <Term>Lungs</Term>
        <Term>Lung Disease</Term>
        <Term>Disorder of lung</Term>
        <Term>Pulmonary Disease</Term>
        <Term>Disease, Pulmonary</Term>
        <Term>Diseases, Pulmonary</Term>
        <Term>Pair of lungs</Term>
        <Term>DISORDER LUNG</Term>
        <Term>Lungs pair</Term>
        <Term>Lung diseases</Term>
        <Term>LUNG DISORDER (NOS)</Term>
        <Term>Set of lungs</Term>
        <Term>Disorder of Lung</Term>
        <Codes>
          <Code code="C1278908" source="C1278908"/>
          <Code code="93880001" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:N-cadherin" name="N-cadherin">
        <Source name="NMVB"/>
        <Term preferred="true">N-cadherin</Term>
        <Relations>
          <Relation name="Broader">NMVB:Immunohistochemical_Profile</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Histological_Type" name="Histological Type">
        <Definition>Refers to the type of tissue in which a tumor originated.</Definition>
        <SemanticType code="T185" name="Classification"/>
        <Source name="NMVB"/>
        <Term preferred="true">Histological Type</Term>
        <Term>Histologic Type</Term>
        <Term>Histologic type</Term>
        <Term>Histological type (attribute)</Term>
        <Term>Histologic type (observable entity)</Term>
        <Term>Histopathologic Type</Term>
        <Term>Histopathology Type</Term>
        <Term>Histology type</Term>
        <Term>Histological type</Term>
        <Codes>
          <Code code="C1317416" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Terminology</Relation>
          <Relation name="Narrower">NMVB:Sarcomatoid_mesothelioma, NMVB:Multicystic_mesothelioma, NMVB:Papillary_mesothelioma, NMVB:Epithelial_or_epithelioid_mesothelioma, NMVB:Biphasic_mesothelioma, NMVB:Desmoplastic_mesothelioma</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Corpus_Uteri" name="Corpus Uteri">
        <Definition>The Corpus uteri, or body of uterus, is the part of the uterus above the isthmus, comprising about two thirds of the non-pregnant organ.</Definition>
        <Definition>The Corpus uteri, or body of uterus, is the part of the uterus above the isthmus, comprising about two thirds of the non-pregnant organ. (NCI)</Definition>
        <Definition>The body of the uterus.</Definition>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <SemanticType code="T033" name="Finding"/>
        <Source name="NMVB"/>
        <Term preferred="true">Corpus Uteri</Term>
        <Term>Corpus uteri</Term>
        <Term>Corpus</Term>
        <Term>Uterine body</Term>
        <Term>Corpus uteri TNM finding</Term>
        <Term>Uterine corpus</Term>
        <Term>body of uterus</Term>
        <Term>corpus</Term>
        <Term>Body of uterus structure</Term>
        <Term>Corpus uteri TNM finding (finding)</Term>
        <Term>Uterus, corpus</Term>
        <Term>corpus of uterus</Term>
        <Term>Uterine Body</Term>
        <Term>Body of uterus structure (body structure)</Term>
        <Term>Body of uterus</Term>
        <Term>CORPUS UTERI</Term>
        <Term>Uterus, Corpus</Term>
        <Codes>
          <Code code="C0227813" source="C0227813"/>
          <Code code="396311006" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Endophytic" name="Endophytic">
        <SemanticType code="T033" name="Finding"/>
        <Source name="NMVB"/>
        <Term preferred="true">Endophytic</Term>
        <Term>Endophytic tumor configuration</Term>
        <Term>Endophytic tumour configuration</Term>
        <Term>Endophytic tumor configuration (finding)</Term>
        <Codes>
          <Code code="399711005" source="399711005"/>
          <Code code="C1302633" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Configuration</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:pleura" name="pleura">
        <Definition>Of or pertaining to the pleura.</Definition>
        <Definition>A thin layer of tissue that covers the lungs and lines the interior wall of the chest cavity. It protects and cushions the lungs. This tissue secretes a small amount of fluid that acts as a lubricant, allowing the lungs to move smoothly in the chest cavity while breathing.</Definition>
        <Definition>The tissue that lines the wall of the thoracic cavity and the surface of the lungs.</Definition>
        <Definition>The thin serous membrane enveloping the lungs (LUNG) and lining the THORACIC CAVITY. Pleura consist of two layers, the inner visceral pleura lying next to the pulmonary parenchyma and the outer parietal pleura. Between the two layers is the PLEURAL CAVITY which contains a thin film of liquid.</Definition>
        <Definition>The tissue that lines the wall of the thoracic cavity and the surface of the lungs. (NCI)</Definition>
        <Definition>The thin serous membrane enveloping the lungs (lung) and lining the thoracic cavity. Pleura consist of two layers, the inner visceral pleura lying next to the pulmonary parenchyma and the outer parietal pleura. Between the two layers is the pleural cavity which contains a thin film of liquid. [MeSH]</Definition>
        <SemanticType code="T082" name="Spatial Concept"/>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <Source name="NMVB"/>
        <Term preferred="true">pleura</Term>
        <Term>Pleural (qualifier value)</Term>
        <Term>Entire pleura</Term>
        <Term>Pleura, NOS</Term>
        <Term>PLEURA</Term>
        <Term>Pleural structure</Term>
        <Term>Pleural</Term>
        <Term>Pleural membrane structure</Term>
        <Term>Pleura</Term>
        <Term>Pleural Tissue</Term>
        <Term>Wall of pleural sac</Term>
        <Term>Pleural membrane structure (body structure)</Term>
        <Term>Entire pleura (body structure)</Term>
        <Codes>
          <Code code="264148002" source="264148002"/>
          <Code code="C1279036" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:NMVB_Template" name="nmvb template">
        <Source name="NMVB"/>
        <Term preferred="true">nmvb template</Term>
        <Relations>
          <Relation name="Broader">NMVB:Template</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Thrombomodulin" name="Thrombomodulin">
        <Definition>Thrombomodulin (575 aa, ~60 kDa) is encoded by the human THBD gene. This protein plays a role in thrombin binding, fibrinolysis and coagulation.</Definition>
        <Definition>A cell surface glycoprotein of endothelial cells that binds thrombin and serves as a cofactor in the activation of protein C and its regulation of blood coagulation.</Definition>
        <Definition>vascular endothelium surface glycoprotein which binds thrombin and accelerates its activation of protein C, thus exerting an anticoagulant and antiinflammatory effect.</Definition>
        <Definition>This gene plays a role in the modulation of blood coagulation.</Definition>
        <SemanticType code="T028" name="Gene or Genome"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="NMVB"/>
        <Term preferred="true">Thrombomodulin</Term>
        <Term>CD141 Antigen</Term>
        <Term>thrombomodulin</Term>
        <Term>Antigen CD141</Term>
        <Term>Thrombomodulin (substance)</Term>
        <Term>THROMBOMODULIN</Term>
        <Term>Thrombomodulin [Chemical/Ingredient]</Term>
        <Term>THBD gene</Term>
        <Term>THBD Gene</Term>
        <Term>THBD</Term>
        <Term>Thrombomodulin Gene</Term>
        <Term>THRM</Term>
        <Term>CD141</Term>
        <Term>BDCA-3</Term>
        <Term>TM</Term>
        <Term>CD141 ANTIGEN</Term>
        <Term>Fetomodulin</Term>
        <Codes>
          <Code code="C1420720" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Immunohistochemical_Profile</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:CK5_6" name="CK5/6">
        <Source name="NMVB"/>
        <Term preferred="true">CK5/6</Term>
        <Relations>
          <Relation name="Broader">NMVB:Immunohistochemical_Profile</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Papillary_mesothelioma" name="Papillary mesothelioma">
        <SemanticType code="T191" name="Neoplastic Process"/>
        <Source name="NMVB"/>
        <Term preferred="true">Papillary mesothelioma</Term>
        <Term>Glandular papilloma</Term>
        <Term>Papillary adenoma (morphologic abnormality)</Term>
        <Term>Papillary adenoma</Term>
        <Codes>
          <Code code="86143001" source="86143001"/>
          <Code code="C0205650" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Histological_Type</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Breast" name="Breast">
        <Definition>Region of pectoral part of chest which has as its parts nipple, areola, breast proper.</Definition>
        <Definition>Subdivision of the pectoral part of the chest which consists of the nipple, areola and breast proper.</Definition>
        <Definition>In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES.</Definition>
        <Definition>One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest. (NCI)</Definition>
        <Definition>Glandular organ located on the chest. The breast is made up of connective tissue, fat, and breast tissue that contains the glands that can make milk.</Definition>
        <Definition>One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.</Definition>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <Source name="NMVB"/>
        <Term preferred="true">Breast</Term>
        <Term>BREAST</Term>
        <Term>Entire breast (body structure)</Term>
        <Term>Breasts</Term>
        <Term>Entire breast</Term>
        <Term>Mammary part of chest</Term>
        <Term>Breast structure</Term>
        <Term>Breast, NOS</Term>
        <Term>Mamma</Term>
        <Term>breast</Term>
        <Term>Breast anatomy</Term>
        <Term>Mammary region</Term>
        <Term>mammary region</Term>
        <Term>Breast structure (body structure)</Term>
        <Codes>
          <Code code="181131000" source="181131000"/>
          <Code code="C1268990" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:leura" name="leura">
        <SemanticType code="T191" name="Neoplastic Process"/>
        <Source name="NMVB"/>
        <Term preferred="true">leura</Term>
        <Term>Cancer of parietal pleura</Term>
        <Term>Malignant neoplasm of parietal pleura (disorder)</Term>
        <Term>Malignant neoplasm of parietal pleura</Term>
        <Codes>
          <Code code="C2004481" source="C2004481"/>
          <Code code="449067008" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Cervix_Uteri" name="Cervix Uteri">
        <Definition>The lower part of the uterus occupying the region between the isthmus of the uterus and the vagina. It is divided into supravaginal and vaginal portions.</Definition>
        <Definition>The neck portion of the UTERUS between the lower isthmus and the VAGINA forming the cervical canal.</Definition>
        <Definition>The lower, narrow end of the uterus that forms a canal between the uterus and vagina.</Definition>
        <Definition>The lower part of the uterus occupying the region between the isthmus of the uterus and the vagina. It is divided into supravaginal and vaginal portions. (NCI)</Definition>
        <Definition>neck portion of the uterus between the lower isthmus and the vagina forming the cervical canal.</Definition>
        <Definition>The neck portion of the uterus between the lower isthmus and the vagina forming the cervical canal. [MeSH]</Definition>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <Source name="NMVB"/>
        <Term preferred="true">Cervix Uteri</Term>
        <Term>cervix of uterus</Term>
        <Term>Uterus, cervix</Term>
        <Term>Cervixes</Term>
        <Term>Cervix, NOS</Term>
        <Term>Cervix uteri</Term>
        <Term>uterine cervix</Term>
        <Term>endocervical canal</Term>
        <Term>Uterine cervix</Term>
        <Term>Neck of uterus</Term>
        <Term>Uterine Cervix</Term>
        <Term>Cervix of uterus</Term>
        <Term>Cervix uteri structure</Term>
        <Term>Cervical canal</Term>
        <Term>Genital System, Female, Cervix</Term>
        <Term>Cervix, Uterine</Term>
        <Term>Cervix uteri including exocervix and endocervix</Term>
        <Term>CERVIX</Term>
        <Term>Cervix uteri structure (body structure)</Term>
        <Term>CERVIX UTERI</Term>
        <Term>Cervical canal of uterus</Term>
        <Term>Entire cervix uteri (body structure)</Term>
        <Term>Entire cervix uteri</Term>
        <Term>cervical canal of uterus</Term>
        <Term>cervical canal</Term>
        <Term>cervix</Term>
        <Term>Canalis cervicis uteri</Term>
        <Term>Cervix</Term>
        <Codes>
          <Code code="C1278987" source="C1278987"/>
          <Code code="181453009" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Mixed" name="Mixed">
        <Definition>A malignant neoplasm composed of a carcinomatous epithelial component and a sarcomatous mesenchymal component. Representative examples include malignant mixed mesodermal (Mullerian) tumor of the female reproductive system and carcinosarcoma of the salivary gland and the lung.</Definition>
        <Definition>Involving or composed of different kinds.</Definition>
        <Definition>Mixed; being composed of a combination of normal and tumor cells.</Definition>
        <Definition>A malignant tumor composed of more than one type of neoplastic tissue. (Dorland, 27th ed)</Definition>
        <Definition>A malignant neoplasm composed of epithelial and/or myoepithelial cells and a mesenchymal component. A general term for which the transformed cell types have not been specified.</Definition>
        <SemanticType code="T033" name="Finding"/>
        <SemanticType code="T191" name="Neoplastic Process"/>
        <SemanticType code="T080" name="Qualitative Concept"/>
        <Source name="NMVB"/>
        <Term preferred="true">Mixed</Term>
        <Term>Mix</Term>
        <Term>Mixed Cell Morphology</Term>
        <Term>Mixed tumor, malignant (morphologic abnormality)</Term>
        <Term>Malignant mixed tumour</Term>
        <Term>Malignant mixed tumor</Term>
        <Term>Mistura</Term>
        <Term>Mixed tumor, malignant</Term>
        <Term>Mixed (Normal and Tumor)</Term>
        <Term>Mist.</Term>
        <Term>Mixed (qualifier value)</Term>
        <Term>Mixed tumour, malignant</Term>
        <Term>MIXED</Term>
        <Term>mixed</Term>
        <Codes>
          <Code code="C3160715" source="C3160715"/>
          <Code code="8145008" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Configuration</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:CK20" name="CK20">
        <Definition>This gene plays a role in the formation of intestinal epithelia.</Definition>
        <Definition>Human KRT20 wild-type allele is located in the vicinity of 17q21.2 and is approximately 9 kb in length. This allele, which encodes keratin, type I cytoskeletal 20 protein, is involved in the modulation of intestinal development.</Definition>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="NMVB"/>
        <Term preferred="true">CK20</Term>
        <Term>K20</Term>
        <Term>Keratin 20 wt Allele</Term>
        <Term>Keratin 20 Gene</Term>
        <Term>CK-20</Term>
        <Term>KERATIN 21, RAT, HOMOLOG OF</Term>
        <Term>MGC35423</Term>
        <Term>KRT20</Term>
        <Term>CYTOKERATIN 20</Term>
        <Term>KRT20 gene</Term>
        <Term>KRT20 Gene</Term>
        <Term>KRT20 wt Allele</Term>
        <Term>CD20</Term>
        <Term>keratin 20</Term>
        <Term>KERATIN 20</Term>
        <Term>KRT21</Term>
        <Codes>
          <Code code="C3272788" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Immunohistochemical_Profile</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Immunohistochemical_Profile_Slot" name="Immunohistochemical Profile Slot">
        <Source name="NMVB"/>
        <Term preferred="true">Immunohistochemical Profile Slot</Term>
        <Relations>
          <Relation name="Broader">NMVB:Slot</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Epithelial_or_epithelioid_mesothelioma" name="Epithelial or epithelioid mesothelioma">
        <Definition>A malignant neoplasm arising from mesothelial cells in the pleura. It is characterized by the presence of neoplastic cells with an epithelioid appearance. In the majority of cases, the neoplastic epithelioid cells lack significant cytologic atypia; mitotic figures are infrequently seen. In a minority of cases, the neoplastic cells are poorly differentiated and there is evidence of nuclear atypia and increased mitotic activity.</Definition>
        <Definition>A malignant neoplasm arising from mesothelial cells in the pleura. It is characterized by the presence of neoplastic cells with an epithelioid appearance. In the majority of cases, the neoplastic epithelioid cells lack significant cytologic atypia; mitotic figures are infrequently seen. In a minority of cases, the neoplastic cells are poorly differentiated and there is evidence of nuclear atypia and increased mitotic activity. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=39969&amp;idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=39969&amp;idtype=1&amp;closed=1" closed clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&amp;code=C7985" NCI Thesaurus)</Definition>
        <SemanticType code="T191" name="Neoplastic Process"/>
        <Source name="NMVB"/>
        <Term preferred="true">Epithelial or epithelioid mesothelioma</Term>
        <Term>Epithelioid mesothelioma</Term>
        <Term>Epithelioid mesothelioma, malignant</Term>
        <Term>Epithelioid mesothelioma, malignant (morphologic abnormality)</Term>
        <Term>Malignant epithelioid mesothelioma</Term>
        <Codes>
          <Code code="65278006" source="65278006"/>
          <Code code="C0862312" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Histological_Type</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:CD44S" name="CD44S">
        <Source name="NMVB"/>
        <Term preferred="true">CD44S</Term>
        <Relations>
          <Relation name="Broader">NMVB:Immunohistochemical_Profile</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:CAE" name="CAE">
        <SemanticType code="T061" name="Therapeutic or Preventive Procedure"/>
        <Source name="NMVB"/>
        <Term preferred="true">CAE</Term>
        <Term>cyclophosphamide/doxorubicin/etoposide</Term>
        <Term>CAVP-16</Term>
        <Term>CDE protocol</Term>
        <Term>AVE</Term>
        <Term>ACE-II</Term>
        <Term>Cyclophosphamide/Doxorubicin/Etoposide</Term>
        <Term>CTX/DOX/VP-16</Term>
        <Term>ACE</Term>
        <Term>CDE protocol-cyclophosphamide/doxorubicin/etoposide</Term>
        <Term>CED</Term>
        <Term>CAVP</Term>
        <Term>CDE</Term>
        <Codes>
          <Code code="C0108844" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Immunohistochemical_Profile</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Diffuse" name="Diffuse">
        <Definition>Widely spread; not localized or confined.</Definition>
        <Definition>[BI-RADS] these are calcifications that are distributed randomly throughout the breast. Punctate and amorphous calcifications in this distribution are usually benign and usually bilateral.[LIRADS]: Distributed over a large area, such as over an entire liver, lobe, or segment, or over an entire observation.</Definition>
        <SemanticType code="T033" name="Finding"/>
        <SemanticType code="T080" name="Qualitative Concept"/>
        <Source name="NMVB"/>
        <Term preferred="true">Diffuse</Term>
        <Term>Diffuse tumor configuration (finding)</Term>
        <Term>diffuse</Term>
        <Term>Diffuse tumor configuration</Term>
        <Term>Diffuse (qualifier value)</Term>
        <Term>Diffuse tumour configuration</Term>
        <Codes>
          <Code code="C0205219" source="C0205219"/>
          <Code code="369747003" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Configuration</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Template" name="template">
        <Source name="NMVB"/>
        <Term preferred="true">template</Term>
        <Relations>
          <Relation name="Broader">owl:Thing</Relation>
          <Relation name="Narrower">NMVB:NMVB_Template</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Additional_Pathologic_Findings" name="Additional Pathologic Findings">
        <SemanticType code="T201" name="Clinical Attribute"/>
        <SemanticType code="T033" name="Finding"/>
        <Source name="NMVB"/>
        <Term preferred="true">Additional Pathologic Findings</Term>
        <Term>Additional pathologic finding</Term>
        <Term>Additional pathologic finding in tumour specimen</Term>
        <Term>Additional pathological findings</Term>
        <Term>Additional pathologic finding in tumor specimen (observable entity)</Term>
        <Term>Additional pathologic finding in tumor specimen</Term>
        <Codes>
          <Code code="C1269799" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Terminology</Relation>
          <Relation name="Narrower">NMVB:Mixed_inflammation, NMVB:Pleural_plaque, NMVB:chronic_inflammation, NMVB:acute_inflammation, NMVB:Ferruginous_bodies, NMVB:pulmonary_interstitial_fibrosis, NMVB:Changes_of_talc_pleurodesis</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Testis" name="Testis">
        <Definition>Lobular organ the parenchyma of which consists of seminiferous tubules which communicate with the duct of the epididymis. Examples: There only two instances, right testis and left testis.</Definition>
        <Definition>One of two egg-shaped glands inside the scrotum that produce sperm and male hormones.</Definition>
        <Definition>The male gonad containing two functional parts: the seminiferous tubules for the production and transport of male germ cells (spermatogenesis) and the interstitial compartment containing leydig cells that produce androgens. [MeSH]</Definition>
        <Definition>male gonad; either of the paired glands normally located in the scrotum; each testis is surround by an outer mesothelial layer and an inner white capsule and is composed of compartments which contain the seminiferous tubules where the spermatozoa are produced; specialized interstital Leydig cells secrete androgens.</Definition>
        <Definition>The male gonad containing two functional parts: the SEMINIFEROUS TUBULES for the production and transport of male germ cells (SPERMATOGENESIS) and the interstitial compartment containing LEYDIG CELLS that produce ANDROGENS.</Definition>
        <Definition>Either of the paired male reproductive glands that produce the male germ cells and the male hormones.</Definition>
        <Definition>Either of the paired male reproductive glands that produce the male germ cells and the male hormones. (NCI)</Definition>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <SemanticType code="T191" name="Neoplastic Process"/>
        <Source name="NMVB"/>
        <Term preferred="true">Testis</Term>
        <Term>testes</Term>
        <Term>testicles</Term>
        <Term>Testis (Orchis)</Term>
        <Term>Testicles</Term>
        <Term>Malignant tumor of retained testis</Term>
        <Term>Entire testis</Term>
        <Term>Testis structure</Term>
        <Term>Cancer of undescended testis</Term>
        <Term>Entire testis (body structure)</Term>
        <Term>Testicle</Term>
        <Term>Testes</Term>
        <Term>Male gonad</Term>
        <Term>testis</Term>
        <Term>Malignant tumor of undescended testis</Term>
        <Term>testicle</Term>
        <Term>Testicle, NOS</Term>
        <Term>Malignant tumour of undescended testis</Term>
        <Term>Testis structure (body structure)</Term>
        <Term>Malignant neoplasm of undescended testis</Term>
        <Term>Malignant tumor of undescended testis (disorder)</Term>
        <Term>set of testicles</Term>
        <Term>Malignant tumour of retained testis</Term>
        <Term>TESTIS</Term>
        <Term>Orchis</Term>
        <Term>Genital System, Male, Testis</Term>
        <Term>Testis, NOS</Term>
        <Codes>
          <Code code="188219004" source="188219004"/>
          <Code code="C1278981" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Tumor_Slot" name="Tumor Slot">
        <Source name="NMVB"/>
        <Term preferred="true">Tumor Slot</Term>
        <Relations>
          <Relation name="Broader">NMVB:Slot</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Additional_Pathologic_Findings_Slot" name="Additional Pathologic Findings Slot">
        <Source name="NMVB"/>
        <Term preferred="true">Additional Pathologic Findings Slot</Term>
        <Relations>
          <Relation name="Broader">NMVB:Slot</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:left_parietal_pleura" name="left parietal pleura">
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <Source name="NMVB"/>
        <Term preferred="true">left parietal pleura</Term>
        <Term>Entire left parietal pleura (body structure)</Term>
        <Term>Entire left parietal pleura</Term>
        <Term>Structure of left parietal pleura</Term>
        <Term>Structure of left parietal pleura (body structure)</Term>
        <Term>Left parietal pleura</Term>
        <Codes>
          <Code code="187338008" source="187338008"/>
          <Code code="C1279246" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Gallbladder" name="Gallbladder">
        <Definition>storage reservoir for bile secretion; allows the delivery of bile acids at a high concentration and in a controlled manner, via the cystic duct to the duodenum, for degradation of dietary lipid.</Definition>
        <Definition>Organ with organ cavity which is continuous proximally with the hepatic duct and distally terminates in the fundus of the gallbladder. Examples: There is only one gallbladder.</Definition>
        <Definition>A primary or metastatic malignant neoplasm that affects the gallbladder. Representative examples include carcinoma, lymphoma, melanoma, and sarcoma.</Definition>
        <Definition>A pear-shaped organ located under the liver that stores and concentrates bile secreted by the liver. From the gallbladder the bile is delivered through the bile ducts into the intestine thereby aiding the digestion of fat-containing foods.</Definition>
        <Definition>A pear-shaped organ located under the liver that stores and concentrates bile secreted by the liver. From the gallbladder the bile is delivered through the bile ducts into the intestine thereby aiding the digestion of fat-containing foods. (NCI)</Definition>
        <Definition>Organ with organ cavity which is continuous proximally with the cystic duct and distally terminates in the fundus of the gallbladder. Examples: There is only one gallbladder.</Definition>
        <Definition>Organ with organ cavity which is continuous proximally with the cystic duct and distally terminates in the fundus of the gallbladder. [FMA]</Definition>
        <Definition>The pear-shaped organ found below the liver. Bile is concentrated and stored in the gallbladder.</Definition>
        <Definition>A storage reservoir for BILE secretion. Gallbladder allows the delivery of bile acids at a high concentration and in a controlled manner, via the CYSTIC DUCT to the DUODENUM, for degradation of dietary lipid.</Definition>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <SemanticType code="T191" name="Neoplastic Process"/>
        <SemanticType code="T024" name="Tissue"/>
        <Source name="NMVB"/>
        <Term preferred="true">Gallbladder</Term>
        <Term>Vesica fellea</Term>
        <Term>Gallbladders</Term>
        <Term>Malignant tumor of gallbladder</Term>
        <Term>Gallbladder structure</Term>
        <Term>Gallbladder Ca</Term>
        <Term>Gallbladder structure (body structure)</Term>
        <Term>Gastrointestinal Tract, Gall Bladder</Term>
        <Term>Mouse Gallbladder</Term>
        <Term>Gallbladder/Biliary system</Term>
        <Term>GALLBLADDER</Term>
        <Term>gallbladder</Term>
        <Term>Gall bladder</Term>
        <Term>GB - Gallbladder</Term>
        <Term>Vesica biliaris</Term>
        <Term>gall bladder</Term>
        <Term>Gallenblase</Term>
        <Term>Entire gallbladder</Term>
        <Term>Vesica biliaris (Fellea)</Term>
        <Term>Malignant tumor of gallbladder (disorder)</Term>
        <Term>Malignant tumour of gallbladder</Term>
        <Term>Gallbladder (MMHCC)</Term>
        <Term>Entire gallbladder (body structure)</Term>
        <Term>Gallbladder / Biliar</Term>
        <Codes>
          <Code code="C1269001" source="C1269001"/>
          <Code code="363353009" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Tumor" name="Tumor">
        <Definition>A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells.</Definition>
        <SemanticType code="T033" name="Finding"/>
        <Source name="NMVB"/>
        <Term>neoplasm</Term>
        <Term preferred="true">Tumor</Term>
        <Term>mesothelioma</Term>
        <Term>tumor</Term>
        <Term>Tumor Mass</Term>
        <Codes>
          <Code code="C3273930" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Terminology</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:PSAD" name="PSAD">
        <Source name="NMVB"/>
        <Term preferred="true">PSAD</Term>
        <Relations>
          <Relation name="Broader">NMVB:Immunohistochemical_Profile</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Skin" name="Skin">
        <Definition>The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.</Definition>
        <Definition>An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages. (NCI)</Definition>
        <Definition>covering of the outer region of the body that protects it from the environment.</Definition>
        <Definition>An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages.</Definition>
        <Definition>A malignant vascular neoplasm arising from blood vessels and lymphatics of the skin.</Definition>
        <Definition>Nonparenchymatous organ that consists of the epidermis, dermis and sets of hair and nails and which surrounds the entire body. Subdivisions of the skin surround various body parts; as a whole, the skin constitutes the external layer of the body. Examples: There is only one skin.</Definition>
        <Definition>Nonparenchymatous organ that consists of the dermis and epidermis. Subdivisions of the skin surround various body parts; as a whole, the skin constitutes the external layer of the body. Examples: There is only one skin.</Definition>
        <SemanticType code="T191" name="Neoplastic Process"/>
        <SemanticType code="T047" name="Disease or Syndrome"/>
        <SemanticType code="T024" name="Tissue"/>
        <SemanticType code="T022" name="Body System"/>
        <Source name="NMVB"/>
        <Term preferred="true">Skin</Term>
        <Term>Cutis</Term>
        <Term>Disorder of the skin and subcutaneous tissue, unspecified</Term>
        <Term>DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE</Term>
        <Term>integument</Term>
        <Term>Skin (tissue) specimen (specimen)</Term>
        <Term>Disorder of skin and subcutaneous tissue</Term>
        <Term>Disorder of skin AND/OR subcutaneous tissue (disorder)</Term>
        <Term>cutaneous tissue</Term>
        <Term>Integument</Term>
        <Term>Skin of body</Term>
        <Term>Skin structure</Term>
        <Term>skin system</Term>
        <Term>Malignant vascular tumor of skin</Term>
        <Term>Tissue specimen from skin</Term>
        <Term>Skin and subcutaneous tissue disorders</Term>
        <Term>Entire skin (body structure)</Term>
        <Term>Malignant vascular tumour of skin</Term>
        <Term>SKIN</Term>
        <Term>Integumental system</Term>
        <Term>Skin sample</Term>
        <Term>Skin structure (body structure)</Term>
        <Term>Malignant vascular tumor of skin (disorder)</Term>
        <Term>Skin Specimen</Term>
        <Term>Diseases of the skin and subcutaneous tissue</Term>
        <Term>Entire skin</Term>
        <Term>Disorder of skin AND/OR subcutaneous tissue</Term>
        <Term>Unspecified disorder of skin and subcutaneous tissue</Term>
        <Term>Skin specimen</Term>
        <Term>Disorder of skin and subcutaneous tissue, unspecified</Term>
        <Term>Diseases of the skin and subcutaneous tissue (L00-L99)</Term>
        <Term>Disorder of the dermis and subcutaneous tissue</Term>
        <Term>Skin (tissue) specimen</Term>
        <Term>Skin and subcutaneous tissue disease</Term>
        <Term>Skin disorder NOS</Term>
        <Term>skin</Term>
        <Codes>
          <Code code="402652009" source="402652009"/>
          <Code code="C1278993" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Pharynx" name="Pharynx">
        <Definition>funnel-shaped fibromuscular tube that conducts food to the esophagus, and air to the larnyx and lungs.</Definition>
        <Definition>A funnel-shaped fibromuscular tube that conducts food to the ESOPHAGUS, and air to the LARYNX and LUNGS. It is located posterior to the NASAL CAVITY; ORAL CAVITY; and LARYNX, and extends from the SKULL BASE to the inferior border of the CRICOID CARTILAGE anteriorly and to the inferior border of the C6 vertebra posteriorly. It is divided into the NASOPHARYNX; OROPHARYNX; and HYPOPHARYNX (laryngopharynx).</Definition>
        <Definition>A primary or metastatic malignant neoplasm that affects the pharynx.</Definition>
        <Definition>A hollow tube that starts posterior to the mouth and nasal cavity and ends superior to the trachea and esophagus.</Definition>
        <Definition>The hollow tube inside the neck that starts behind the nose and ends at the top of the trachea (windpipe) and esophagus (the tube that goes to the stomach). The pharynx is about 5 inches long, depending on body size.</Definition>
        <Definition>A hollow tube that starts posterior to the mouth and nasal cavity and ends superior to the trachea and esophagus. (NCI)</Definition>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <SemanticType code="T191" name="Neoplastic Process"/>
        <Source name="NMVB"/>
        <Term preferred="true">Pharynx</Term>
        <Term>Pharyngeal structure (body structure)</Term>
        <Term>Pharyngeal structure</Term>
        <Term>Throats</Term>
        <Term>Malignant tumour of pharynx</Term>
        <Term>Entire pharynx</Term>
        <Term>throat</Term>
        <Term>CA - Cancer of pharynx</Term>
        <Term>PHARYNX</Term>
        <Term>Malignant tumor of pharynx</Term>
        <Term>Entire pharynx (body structure)</Term>
        <Term>Throat</Term>
        <Term>Malignant tumor of pharynx (disorder)</Term>
        <Term>Pharynx, NOS</Term>
        <Term>Cancer of pharynx</Term>
        <Term>pharynx</Term>
        <Term>Pharynxs</Term>
        <Codes>
          <Code code="C1278903" source="Code"/>
          <Code code="363507003" source="363507003"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Liver" name="Liver">
        <Definition>Lobular organ the parenchyma of which consists of lobules which communicate with the biliary tree. Examples: There is only one liver.</Definition>
        <Definition>Lobular organ which has as its parts lobules connected to the biliary tree. Examples: There is only one liver.</Definition>
        <Definition>&lt;p&gt;Your liver is the largest organ inside your body. It helps your body digest food, store energy, and remove poisons. Primary liver cancer starts in the liver. Metastatic liver cancer starts somewhere else and spreads to your liver. &lt;/p&gt;&lt;p&gt;Risk factors for primary liver cancer include &lt;/p&gt;&lt;ul&gt;&lt;li&gt;Having &lt;a href='http://www.nlm.nih.gov/medlineplus/hepatitisb.html'&gt;hepatitis B&lt;/a&gt; or &lt;a href='http://www.nlm.nih.gov/medlineplus/hepatitisc.html'&gt;C&lt;/a&gt;&lt;/li&gt;&lt;li&gt;Heavy alcohol use&lt;/li&gt;&lt;li&gt;Having &lt;a href='http://www.nlm.nih.gov/medlineplus/cirrhosis.html'&gt;cirrhosis&lt;/a&gt;, or scarring of the liver&lt;/li&gt;&lt;li&gt;Having &lt;a href='http://www.nlm.nih.gov/medlineplus/hemochromatosis.html'&gt;hemochromatosis&lt;/a&gt;, an iron storage disease&lt;/li&gt;&lt;li&gt;Obesity and diabetes&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;Symptoms can include a lump or pain on the right side of your abdomen and yellowing of the skin. However, you may not have symptoms until the cancer is advanced. This makes it harder to treat. Doctors use tests that examine the liver and the blood diagnose liver cancer. Treatment options include surgery, radiation, chemotherapy, or &lt;a href='http://www.nlm.nih.gov/medlineplus/livertransplantation.html'&gt;liver transplantation&lt;/a&gt;. &lt;/p&gt;&lt;p &gt;NIH: National Cancer Institute&lt;/p&gt;</Definition>
        <Definition>A large organ located in the upper abdomen. The liver cleanses the blood and aids in digestion by secreting bile.</Definition>
        <Definition>A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate. (NCI)</Definition>
        <Definition>large gland of a dark-red color situated in the upper part of the abdomen on the right side; comprised of thousands of minute lobules, the functional units of the liver; functions include the storage and filtration of blood, secretion of bile, excretion of bilirubin and other substances formed elsewhere, and numerous metabolic functions, including the conversion of sugars into glycogen, which it stores.</Definition>
        <Definition>A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.</Definition>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <SemanticType code="T037" name="Injury or Poisoning"/>
        <SemanticType code="T191" name="Neoplastic Process"/>
        <Source name="NMVB"/>
        <Term preferred="true">Liver</Term>
        <Term>Hepatic Body System</Term>
        <Term>Entire liver (body structure)</Term>
        <Term>Gastrointestinal Tract, Liver</Term>
        <Term>Hepar</Term>
        <Term>Malignant neoplasm of liver</Term>
        <Term>HEPATIC: HEPATOCELLULAR</Term>
        <Term>Malignant tumour of liver</Term>
        <Term>Entire liver</Term>
        <Term>Livers</Term>
        <Term>Liver cancer</Term>
        <Term>liver</Term>
        <Term>Liver structure</Term>
        <Term>Organ System, Hepatic</Term>
        <Term>Hepatic Organ System</Term>
        <Term>Liver structure (body structure)</Term>
        <Term>Body System, Hepatic</Term>
        <Term>Malignant tumor of liver</Term>
        <Term>LIVER</Term>
        <Term>CA - Liver cancer</Term>
        <Term>Malignant neoplasm of liver (disorder)</Term>
        <Codes>
          <Code code="C1278929" source="C1278929"/>
          <Code code="93870000" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Kidney" name="Kidney">
        <Definition>Primary or metastatic malignant neoplasm involving the kidney.</Definition>
        <Definition>Body organ that filters blood for the secretion of URINE and that regulates ion concentrations.</Definition>
        <Definition>One of a pair of organs in the abdomen. Kidneys remove waste from the blood (as urine), produce erythropoietin (a substance that stimulates red blood cell production), and play a role in blood pressure regulation.</Definition>
        <Definition>&lt;p&gt;You have two kidneys. They are fist-sized organs on either side of your backbone above your waist. The tubes inside filter and clean your blood, taking out waste products and making urine. Kidney cancer forms in the lining of tiny tubes inside your kidneys. &lt;/p&gt; &lt;p&gt;Kidney cancer becomes more likely as you age. Risk factors include smoking, having certain genetic conditions, and misusing pain medicines for a long time.&lt;/p&gt;&lt;p&gt;You may have no symptoms at first. They may appear as the cancer grows. See your health care provider if you notice&lt;/p&gt;&lt;ul&gt;&lt;li&gt;Blood in your urine&lt;/li&gt;&lt;li&gt;A lump in your abdomen&lt;/li&gt;&lt;li&gt;Weight loss for no reason&lt;/li&gt;&lt;li&gt;Pain in your side that does not go away&lt;/li&gt;&lt;li&gt;Loss of appetite&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;Treatment depends on your age, your overall health and how advanced the cancer is. It might include surgery, chemotherapy, or radiation, biologic, or targeted therapies. Biologic therapy boosts your body's own ability to fight cancer. Targeted therapy uses substances that attack cancer cells without harming normal cells.&lt;/p&gt;&lt;p &gt;NIH: National Cancer Institute&lt;/p&gt;</Definition>
        <Definition>Tissue composed of the renal cortex and the renal medulla. The basic functional unit of renal tissue is the nephron.</Definition>
        <Definition>body organ that filters blood for the secretion of urine and that regulates ion concentrations.</Definition>
        <Definition>One of the two bean-shaped organs located on each side of the spine in the retroperitoneum. The right kidney is located below the liver and the left kidney below the diaphragm. The kidneys filter and secret the metabolic products and minerals from the blood, thus maintaining the homeostasis. On the superior pole of each kidney there is an adrenal gland. Each kidney and adrenal gland is surrounded by fat.</Definition>
        <Definition>Body organ that filters blood for the secretion of urine and that regulates ion concentrations. [MeSH]</Definition>
        <Definition>Tissue composed of the renal cortex and the renal medulla. The basic functional unit of renal tissue is the nephron. (NCI)</Definition>
        <Definition>One of the two bean-shaped organs located on each side of the spine in the retroperitoneum. The right kidney is located below the liver and the left kidney below the diaphragm. The kidneys filter and secret the metabolic products and minerals from the blood, thus maintaining the homeostasis. On the superior pole of each kidney there is an adrenal gland. Each kidney and adrenal gland is surrounded by fat. (NCI)</Definition>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <SemanticType code="T191" name="Neoplastic Process"/>
        <SemanticType code="T024" name="Tissue"/>
        <Source name="NMVB"/>
        <Term preferred="true">Kidney</Term>
        <Term>renal</Term>
        <Term>Kidney, NOS</Term>
        <Term>Nephros</Term>
        <Term>Urinary System, Kidney</Term>
        <Term>Ren (Nephros)</Term>
        <Term>Renal structure</Term>
        <Term>Entire kidney</Term>
        <Term>Entire kidney (body structure)</Term>
        <Term>CA - Cancer of kidney</Term>
        <Term>Ren</Term>
        <Term>Malignant tumor of kidney</Term>
        <Term>Renal cancer</Term>
        <Term>Malignant tumor of kidney (disorder)</Term>
        <Term>Kidney structure (body structure)</Term>
        <Term>Renal Tissue</Term>
        <Term>nephr(o)-</Term>
        <Term>kidney</Term>
        <Term>Kidneys</Term>
        <Term>ren(o)-</Term>
        <Term>Renal malignant tumor</Term>
        <Term>Renal malignant tumour</Term>
        <Term>CA - Renal cancer</Term>
        <Term>Malignant tumour of kidney</Term>
        <Term>Kidney structure</Term>
        <Term>KIDNEY</Term>
        <Codes>
          <Code code="C1278978" source="C1278978"/>
          <Code code="363518003" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Diaphragmatic_pleura" name="Diaphragmatic pleura">
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <Source name="NMVB"/>
        <Term preferred="true">Diaphragmatic pleura</Term>
        <Term>Structure of diaphragmatic pleura</Term>
        <Term>diaphragmatic pleura</Term>
        <Term>Diaphragmatic part of parietal pleura</Term>
        <Term>Structure of diaphragmatic pleura (body structure)</Term>
        <Term>Pars diaphragmatica pleurae parietalis</Term>
        <Term>Pars diaphragmatica (pleurae)</Term>
        <Term>Entire diaphragmatic pleura</Term>
        <Term>Entire diaphragmatic pleura (body structure)</Term>
        <Codes>
          <Code code="202302008" source="202302008"/>
          <Code code="C1279463" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Surgical_Margins_Slot" name="Surgical Margins Slot">
        <Source name="NMVB"/>
        <Term preferred="true">Surgical Margins Slot</Term>
        <Relations>
          <Relation name="Broader">NMVB:Slot</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Positive_for_mesothelioma" name="involved">
        <Source name="NMVB"/>
        <Term preferred="true">involved</Term>
        <Term>positive</Term>
        <Term form="RegEx">(tumor|mesothelioma) extends</Term>
        <Term>Positive for mesothelioma</Term>
        <Relations>
          <Relation name="Broader">NMVB:Surgical_Margins_Modifiers</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Terminology" name="Terminology">
        <Source name="NMVB"/>
        <Term preferred="true">Terminology</Term>
        <Relations>
          <Relation name="Broader">owl:Thing</Relation>
          <Relation name="Narrower">NMVB:Tumor, NMVB:Histochemical_Special_Stain_Profile, NMVB:Tumor_Dimension, NMVB:Additional_Pathologic_Findings, NMVB:Tumor_Site, NMVB:Attributes, NMVB:Immunohistochemical_Profile, NMVB:Surgical_Margins, NMVB:Histological_Type</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Surgical_Margins_Modifiers" name="Surgical_Margins_Modifiers">
        <Source name="NMVB"/>
        <Term preferred="true">Surgical_Margins_Modifiers</Term>
        <Relations>
          <Relation name="Broader">NMVB:Attributes</Relation>
          <Relation name="Narrower">NMVB:Negative_for_mesothelioma, NMVB:Positive_for_mesothelioma</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Biphasic_mesothelioma" name="Biphasic mesothelioma">
        <Definition>A malignant neoplasm arising from mesothelial cells in the pleura. It is characterized by the presence of neoplastic epithelioid cells and sarcomatoid features.</Definition>
        <SemanticType code="T191" name="Neoplastic Process"/>
        <Source name="NMVB"/>
        <Term preferred="true">Biphasic mesothelioma</Term>
        <Term>Mesothelioma, biphasic</Term>
        <Term>Biphasic Mesothelioma</Term>
        <Term>Mesothelioma, biphasic, malignant</Term>
        <Term>Malignant biphasic mesothelioma</Term>
        <Term>Malignant Biphasic Mesothelioma</Term>
        <Term>Mesothelioma, biphasic, malignant (morphologic abnormality)</Term>
        <Term>biphasic mesothelioma</Term>
        <Term>Mixed Mesothelioma</Term>
        <Term>Mesothelioma, biphasic, NOS</Term>
        <Term>Malignant Mixed Mesothelioma</Term>
        <Codes>
          <Code code="C0334515" source="C0334515"/>
          <Code code="30383009" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Histological_Type</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Pleural_plaque" name="Pleural plaque">
        <SemanticType code="T190" name="Anatomical Abnormality"/>
        <Source name="NMVB"/>
        <Term preferred="true">Pleural plaque</Term>
        <Term>pleural plaque</Term>
        <Term>asbestos-related pleural disease</Term>
        <Term>Pleural plaque (disorder)</Term>
        <Term>Pleural plaque NOS</Term>
        <Codes>
          <Code code="233658003" source="233658003"/>
          <Code code="C0340030" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Additional_Pathologic_Findings</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Spleen" name="Spleen">
        <Definition>An organ that is part of the lymphatic system. The spleen produces lymphocytes, filters the blood, stores blood cells, and destroys old blood cells. It is located on the left side of the abdomen near the stomach.</Definition>
        <Definition>An organ that is part of the hematopoietic and immune systems. It is composed of the white pulp and the red pulp and is surrounded by a capsule. It is located in the left hypochondriac region. Its functions include lymphocyte production, blood cell storage, and blood cell destruction. (NCI)</Definition>
        <Definition>A malignant neoplasm affecting the spleen. Representative examples include leukemias, lymphomas, and sarcomas.</Definition>
        <Definition>glandlike ductless organ situated in the upper abdominal cavity; it gives rise to new red blood cells in fetus and newborn, disintegrates red blood cells, serves as a blood reservoir, and produces lymphocytes and plasma cells.</Definition>
        <Definition>An organ that is part of the hematopoietic and immune systems. It is composed of the white pulp and the red pulp and is surrounded by a capsule. It is located in the left hypochondriac region. Its functions include lymphocyte production, blood cell storage, and blood cell destruction.</Definition>
        <Definition>The largest mass of lymphatic tissue in the body. It consists of cells and vessels contained within a capsule lined by mesothelium, from which trabecula enter the splenic parenchyma. The parenchyma is supported by a framework of reticular fibers. The spleen consists of two types of parenchymal tissue, the white and red pulp. The white pulp is composed of elongated cords of compact lymphatic tissue containing nodules. The red pulp is composed of pulp cords and splenic sinusoids.</Definition>
        <Definition>The largest mass of lymphatic tissue in the body. It consists of cells and vessels contained within a capsule lined by mesothelium, from which trabecula enter the splenic parenchyma. The parenchyma is supported by a framework of reticular fibers. The spleen consists of two types of parenchymal tissue, the white and red pulp. The white pulp is composed of elongated cords of compact lymphatic tissue containing nodules. The red pulp is composed of pulp cords and splenic sinusoids. (NCI)</Definition>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <SemanticType code="T191" name="Neoplastic Process"/>
        <SemanticType code="T024" name="Tissue"/>
        <Source name="NMVB"/>
        <Term preferred="true">Spleen</Term>
        <Term>Entire spleen (body structure)</Term>
        <Term>SPLEEN</Term>
        <Term>Splenic structure</Term>
        <Term>Malignant tumor of spleen</Term>
        <Term>Reticuloendothelial System, Spleen</Term>
        <Term>Malignant tumour of spleen</Term>
        <Term>Splen</Term>
        <Term>Entire spleen</Term>
        <Term>Lien</Term>
        <Term>Splenic structure (body structure)</Term>
        <Term>Malignant tumor of spleen (disorder)</Term>
        <Term>Spleens</Term>
        <Term>spleen</Term>
        <Term>Splenic</Term>
        <Term>Splenic Tissue</Term>
        <Term>Spleen Tissue</Term>
        <Term>splenic</Term>
        <Codes>
          <Code code="363499005" source="363499005"/>
          <Code code="C1278932" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Stomach" name="Stomach">
        <Definition>A primary or metastatic malignant neoplasm involving the stomach.</Definition>
        <Definition>Pathological processes involving the STOMACH.</Definition>
        <Definition>organ of digestion situated in the left upper quadrant of the abdomen between the termination of the esophagus and the beginning of the duodenum.</Definition>
        <Definition>Organ with organ cavity which is continuous proximally with the esophagus and distally with the small intestine. Examples: There is only one stomach.</Definition>
        <Definition>An organ located under the diaphragm, between the liver and the spleen as well as between the esophagus and the small intestine. The stomach is the primary organ of food digestion. (NCI)</Definition>
        <Definition>&lt;p&gt;Your stomach is an organ between your esophagus and small intestine. It is where digestion of protein begins. The stomach has three tasks. It stores swallowed food. It mixes the food with stomach acids. Then it sends the mixture on to the small intestine.&lt;/p&gt;&lt;p&gt;Most people have a problem with their stomach at one time or another. &lt;a href='http://www.nlm.nih.gov/medlineplus/indigestion.html'&gt;Indigestion&lt;/a&gt; and &lt;a href='http://www.nlm.nih.gov/medlineplus/heartburn.html'&gt;heartburn&lt;/a&gt; are common problems. You can relieve some stomach problems with over-the-counter medicines and lifestyle changes, such as avoiding fatty foods or eating more slowly. Other problems like &lt;a href='http://www.nlm.nih.gov/medlineplus/pepticulcer.html'&gt;peptic ulcers&lt;/a&gt; or &lt;a href='http://www.nlm.nih.gov/medlineplus/gerd.html'&gt;GERD&lt;/a&gt; require medical attention. &lt;/p&gt;&lt;p&gt;You should see a doctor if you have any of the following:&lt;/p&gt;&lt;ul&gt; &lt;li&gt;Blood when you have a bowel movement&lt;/li&gt; &lt;li&gt;Severe &lt;a href='http://www.nlm.nih.gov/medlineplus/abdominalpain.html'&gt;abdominal pain&lt;/a&gt;&lt;/li&gt; &lt;li&gt;Heartburn not relieved by antacids &lt;/li&gt; &lt;li&gt;Unintended weight loss &lt;/li&gt; &lt;li&gt;Ongoing vomiting or diarrhea&lt;/li&gt;&lt;/ul&gt;&lt;p &gt;NIH: National Institute of Diabetes and Digestive and Kidney Diseases&lt;/p&gt;</Definition>
        <Definition>The tissue of the stomach. It is composed of a fibrous outer layer bounded by smooth muscle, the submucosa, and the mucosa. The mucosa of the stomach consists of secretory cells that produce hydrochloric acid and gastric enzymes.</Definition>
        <Definition>An organ that is part of the digestive system. It helps in the digestion of food by mixing it with digestive juices and churning it into a thin liquid.</Definition>
        <Definition>An organ located under the diaphragm, between the liver and the spleen as well as between the esophagus and the small intestine. The stomach is the primary organ of food digestion.</Definition>
        <Definition>condition in which there is a deviation from or interruption of the normal structure or function of the stomach.</Definition>
        <Definition>The tissue of the stomach. It is composed of a fibrous outer layer bounded by smooth muscle, the submucosa, and the mucosa. The mucosa of the stomach consists of secretory cells that produce hydrochloric acid and gastric enzymes. (NCI)</Definition>
        <Definition>A non-neoplastic or neoplastic disorder that affects the stomach. Representative examples of non-neoplastic disorders include gastritis and gastric ulcer. Representative examples of neoplastic disorders include adenomas, carcinomas, and lymphomas.</Definition>
        <Definition>Organ with organ cavity which is continuous proximally with the esophagus and distally with the small intestine. [FMA]</Definition>
        <Definition>An organ of digestion situated in the left upper quadrant of the abdomen between the termination of the ESOPHAGUS and the beginning of the DUODENUM.</Definition>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <SemanticType code="T191" name="Neoplastic Process"/>
        <SemanticType code="T047" name="Disease or Syndrome"/>
        <SemanticType code="T024" name="Tissue"/>
        <Source name="NMVB"/>
        <Term preferred="true">Stomach</Term>
        <Term>Gastric disorders</Term>
        <Term>Stomach Diseases [Disease/Finding]</Term>
        <Term>Stomach Disease</Term>
        <Term>Gastric Disorders</Term>
        <Term>stomach</Term>
        <Term>Disorder of stomach</Term>
        <Term>stomach disorder</Term>
        <Term>Malignant tumor of stomach (disorder)</Term>
        <Term>Entire stomach</Term>
        <Term>CA - Cancer of stomach</Term>
        <Term>Diseases, Gastric</Term>
        <Term>Disorder of stomach (disorder)</Term>
        <Term>Entire stomach (body structure)</Term>
        <Term>Gastric disorder</Term>
        <Term>Cancer of stomach</Term>
        <Term>Gastropathy</Term>
        <Term>Gastric Diseases</Term>
        <Term>Stomach structure</Term>
        <Term>Disease, Stomach</Term>
        <Term>Ventriculus</Term>
        <Term>GASTRIC DIS</Term>
        <Term>Stomach Diseases</Term>
        <Term>STOMACH</Term>
        <Term>Gaster</Term>
        <Term>gastric disorder</Term>
        <Term>Gastric cancer</Term>
        <Term>Malignant tumour of stomach</Term>
        <Term>Stomach Disorders</Term>
        <Term>Malignant tumor of stomach</Term>
        <Term>Gastrointestinal Tract, Stomach</Term>
        <Term>Gastric Tissue</Term>
        <Term>Stomach structure (body structure)</Term>
        <Term>Disease, Gastric</Term>
        <Term>Stomachs</Term>
        <Term>Diseases, Stomach</Term>
        <Term>Gastric</Term>
        <Term>gastr(o)-</Term>
        <Term>Stomach Disorder</Term>
        <Term>Gastric Disease</Term>
        <Term>Stomach, NOS</Term>
        <Term>STOMACH DIS</Term>
        <Codes>
          <Code code="363349007" source="363349007"/>
          <Code code="C1278920" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Sarcomatoid_mesothelioma" name="Sarcomatoid mesothelioma">
        <Source name="NMVB"/>
        <Term preferred="true">Sarcomatoid mesothelioma</Term>
        <Relations>
          <Relation name="Broader">NMVB:Histological_Type</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:AE1_3" name="AE1/3">
        <Source name="NMVB"/>
        <Term preferred="true">AE1/3</Term>
        <Relations>
          <Relation name="Broader">NMVB:Immunohistochemical_Profile</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Left_visceral_pleura" name="Left visceral pleura">
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <Source name="NMVB"/>
        <Term preferred="true">Left visceral pleura</Term>
        <Term>Entire left visceral pleura</Term>
        <Term>Structure of left visceral pleura</Term>
        <Term>Structure of left visceral pleura (body structure)</Term>
        <Term>Entire left visceral pleura (body structure)</Term>
        <Codes>
          <Code code="187240001" source="187240001"/>
          <Code code="C1279245" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:High" name="High">
        <Definition>An index used in neuroblastic tumors indicating the presence of more than 200 mitoses and karyorrhexis per 5,000 cells.</Definition>
        <Definition>&lt;p&gt;Indicates the condition may be life-threatening or has the potential to cause permanent injury.&lt;/p&gt;</Definition>
        <Definition>&lt;p&gt;High priority messages are available&lt;/p&gt;</Definition>
        <Definition>An elevated level or position or degree; greater than normal in degree or intensity or amount.</Definition>
        <Definition>&lt;p&gt;Above high normal (for quantitative observations)&lt;/p&gt;</Definition>
        <Definition>&lt;p&gt;&lt;b&gt;Description:&lt;/b&gt;Exposure to an agent at a relatively high level above background.&lt;/p&gt;</Definition>
        <SemanticType code="T078" name="Idea or Concept"/>
        <SemanticType code="T033" name="Finding"/>
        <SemanticType code="T080" name="Qualitative Concept"/>
        <SemanticType code="T081" name="Quantitative Concept"/>
        <Source name="NMVB"/>
        <Term preferred="true">High</Term>
        <Term>Highly</Term>
        <Term>High (qualifier value)</Term>
        <Term>Observation Value - High</Term>
        <Term>Exposure level - high</Term>
        <Term>High Mitosis-Karyorrhexis Index</Term>
        <Term>Higher</Term>
        <Term>elevated</Term>
        <Term>Elevated</Term>
        <Term>high</Term>
        <Term>High grade histologic differentiation (finding)</Term>
        <Term>High grade histologic differentiation</Term>
        <Term>Message Waiting Priority - High</Term>
        <Codes>
          <Code code="CL480873" source="CL480873"/>
          <Code code="399611001" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Differentiation_or_Grade</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Vimentin" name="Vimentin">
        <Definition>This gene plays an important role in cytoskeletal structure during embryogenesis.</Definition>
        <Definition>An intermediate filament protein found in most differentiating cells, in cells grown in tissue culture, and in certain fully differentiated cells. Its insolubility suggests that it serves a structural function in the cytoplasm. MW 52,000.</Definition>
        <Definition>Human vimentin protein (465 aa, ~53.5 kDa) is encoded by the human vimentin (VIM) gene. This phosphoprotein is a structural protein belonging to the intermediate filament family and is highly expressed in fibroblasts.</Definition>
        <Definition>OBSOLETE. A type of intermediate filament. [ISBN:0716731363]</Definition>
        <Definition>principle structural glycoprotein of intermediate filaments in muscle, neuroglia, and other nonepithelial cell types.</Definition>
        <SemanticType code="T026" name="Cell Component"/>
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="NMVB"/>
        <Term preferred="true">Vimentin</Term>
        <Term>Vimentin Protein</Term>
        <Term>VIMENTIN</Term>
        <Term>VIM Gene</Term>
        <Term>vimentin location</Term>
        <Term>Vimentin (substance)</Term>
        <Term>VIM</Term>
        <Term>Vimentin [Chemical/Ingredient]</Term>
        <Term>VIM gene</Term>
        <Term>vimentin</Term>
        <Term>CATARACT, PULVERULENT, AUTOSOMAL DOMINANT</Term>
        <Term>Vimentin Gene</Term>
        <Codes>
          <Code code="C1325833" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Immunohistochemical_Profile</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Colon" name="Colon">
        <Definition>The longest part of the large intestine, which is a tube-like organ connected to the small intestine at one end and the anus at the other. The colon removes water and some nutrients and electrolytes from partially digested food. The remaining material, solid waste called stool, moves through the colon to the rectum and leaves the body through the anus.</Definition>
        <Definition>The segment of LARGE INTESTINE between the CECUM and the RECTUM. It includes the ASCENDING COLON; the TRANSVERSE COLON; the DESCENDING COLON; and the SIGMOID COLON.</Definition>
        <Definition>part of the large intestine that extends from the cecum to the rectum.</Definition>
        <Definition>The part of the large intestine measured from the cecum to the rectum consisting of ascending, transverse, descending and sigmoid portions. The purpose of the colon is to remove water from digested food prior to excretion.</Definition>
        <Definition>The part of the large intestine measured from the cecum to the rectum consisting of ascending, transverse, descending and sigmoid portions. The purpose of the colon is to remove water from digested food prior to excretion. (NCI)</Definition>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <Source name="NMVB"/>
        <Term preferred="true">Colon</Term>
        <Term>colon</Term>
        <Term>Colon part</Term>
        <Term>Colon structure (body structure)</Term>
        <Term>LARGE INTESTINE, COLON</Term>
        <Term>Colon structure</Term>
        <Term>Colon, NOS</Term>
        <Term>COLON</Term>
        <Term>Colonic (qualifier value)</Term>
        <Term>Colon part (body structure)</Term>
        <Term>Entire colon</Term>
        <Term>Colonic</Term>
        <Term>Entire colon (body structure)</Term>
        <Codes>
          <Code code="372174009" source="Code"/>
          <Code code="C1281569" source="C1281569"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Tumor_Site" name="Tumor Site">
        <SemanticType code="T082" name="Spatial Concept"/>
        <Source name="NMVB"/>
        <Term preferred="true">Tumor Site</Term>
        <Term>Site of tumor</Term>
        <Term>Site of neoplasm (attribute)</Term>
        <Term>Site of neoplasm</Term>
        <Term>Tumour site</Term>
        <Term>Tumor site</Term>
        <Term>Tumor site (observable entity)</Term>
        <Term>Site of tumor (attribute)</Term>
        <Term>Site of tumour</Term>
        <Codes>
          <Code code="C0475445" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Terminology</Relation>
          <Relation name="Narrower">NMVB:pleura, NMVB:Parotid_Other_Glands, NMVB:Urinary_Bladder, NMVB:Stomach, NMVB:Larynx, NMVB:Brain_CNS, NMVB:Diaphragmatic_pleura, NMVB:left_pleura, NMVB:Rectosigmoid, NMVB:Esophagus, NMVB:Kidney, NMVB:Right_visceral_pleura, NMVB:Breast, NMVB:Bones, NMVB:Oral_Cavity, NMVB:Corpus_Uteri, NMVB:Anus, NMVB:Appendix, NMVB:Testis, NMVB:Renal_Pelvis, NMVB:Gallbladder, NMVB:Adrenal, NMVB:peritoneum, NMVB:right_pleura, NMVB:Ureter, NMVB:Ovary, NMVB:Pharynx, NMVB:Lung, NMVB:Skin, NMVB:Cervix_Uteri, NMVB:leura, NMVB:Rectum, NMVB:Leukemia, NMVB:Pancreatic, NMVB:pelvic_peritoneum, NMVB:Left_visceral_pleura, NMVB:Lymph_node, NMVB:left_parietal_pleura, NMVB:Head_Neck, NMVB:Right_parietal_pleura, NMVB:Spleen, NMVB:Colon, NMVB:Liver, NMVB:pericardium, NMVB:Thyroid, NMVB:Prostate</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:right_pleura" name="right pleura">
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <Source name="NMVB"/>
        <Term preferred="true">right pleura</Term>
        <Term>Right pleural sac membrane</Term>
        <Term>Membrane of right pleural sac</Term>
        <Term>Right pleura structure</Term>
        <Term>Right pleura structure (body structure)</Term>
        <Term>Right pleura</Term>
        <Term>Entire right pleura (body structure)</Term>
        <Term>Entire right pleura</Term>
        <Codes>
          <Code code="C1183942" source="C1183942"/>
          <Code code="362000000" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:pulmonary_interstitial_fibrosis" name="pulmonary interstitial fibrosis">
        <Definition>Chronic progressive interstitial lung disorder characterized by the replacement of the lung tissue by connective tissue, leading to progressive dyspnea, respiratory failure, or right heart failure. Causes include chronic inflammatory processes, exposure to environmental irritants, radiation therapy, autoimmune disorders, certain drugs, or it may be idiopathic (no identifiable cause).</Definition>
        <Definition>A interstitial lung disease characterized by the replacement of lung tissue with connective tissue. (AE)</Definition>
        <Definition>A disorder characterized by the replacement of the lung tissue by connective tissue, leading to progressive dyspnea, respiratory failure or right heart failure.</Definition>
        <Definition>&lt;p&gt;Pulmonary fibrosis harms the tissues deep in your lungs. The air sacs in your lungs and their supporting structures become scarred and make your lungs thick and stiff. That makes it hard for you to catch your breath, and your blood may not get enough oxygen.&lt;/p&gt;&lt;p&gt;One cause of pulmonary fibrosis is &lt;a href='http://www.nlm.nih.gov/medlineplus/interstitiallungdiseases.html'&gt;interstitial lung disease&lt;/a&gt;. Interstitial lung disease is the name for a large group of diseases that inflame or scar the lungs. Pulmonary fibrosis is also associated with some connective tissue diseases. It can be a side effect of a medicine. Sometimes no one knows the cause of the disease. Smoking can boost your risk or make your illness worse&lt;/p&gt;</Definition>
        <Definition>A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.</Definition>
        <SemanticType code="T047" name="Disease or Syndrome"/>
        <Source name="NMVB"/>
        <Term preferred="true">pulmonary interstitial fibrosis</Term>
        <Term>Cirrhosis of lung</Term>
        <Term>Interstitial fibrosis</Term>
        <Term>Interstitial lung fibrosis</Term>
        <Term>FIBROSIS, INTERSTITIAL</Term>
        <Term>Pulmonary Fibrosis [Disease/Finding]</Term>
        <Term>Fibrosis pulmonary</Term>
        <Term>FIBROSIS PULMONARY</Term>
        <Term>FIBROSIS PULM</Term>
        <Term>PULM FIBROSIS</Term>
        <Term>LUNG FIBROSIS</Term>
        <Term>PULM FIBROSES</Term>
        <Term>FIBROSES PULM</Term>
        <Term>LUNG FIBROSIS INTERSTITIAL</Term>
        <Term>pulmonary fibrosis</Term>
        <Term>Fibrosis of lung (disorder)</Term>
        <Term>Interstitial pulmonary fibrosis</Term>
        <Term>interstitial fibrosis</Term>
        <Term>Lung fibrosis interstitial</Term>
        <Term>Fibrosis of lung</Term>
        <Term>Fibroses, Pulmonary</Term>
        <Term>Fibrosis, Pulmonary</Term>
        <Term>FIBROSIS LUNG</Term>
        <Term>Pulmonary Fibroses</Term>
        <Term>Lung fibrosis</Term>
        <Term>Fibrosis lung</Term>
        <Term>INTERSTITIAL PULMONARY FIBROSIS</Term>
        <Term>Pulmonary Interstitial Fibrosis</Term>
        <Term>Interstitial fibrosis (morphologic abnormality)</Term>
        <Term>PULMONARY FIBROSIS</Term>
        <Term>Pulmonary fibrosis</Term>
        <Term>Pulmonary Fibrosis</Term>
        <Codes>
          <Code code="C0240035" source="C0240035"/>
          <Code code="125565008" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Additional_Pathologic_Findings</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Esophagus" name="Esophagus">
        <Definition>The portion of the digestive canal between the pharynx and stomach. It consists of three parts: the cervical part, from the cricoid cartilage to the thoracic inlet; thoracic part, from thoracic inlet to the diaphragm; and abdominal part, below the diaphragm to the cardiac opening of the stomach.</Definition>
        <Definition>disorder of the esophagus, the portion of the digestive canal between the pharynx and stomach.</Definition>
        <Definition>The muscular tube through which food passes from the throat to the stomach.</Definition>
        <Definition>Organ with organ cavity which is continuous proximally with the pharynx and distally with the stomach. Examples: There is only one esophagus.</Definition>
        <Definition>Organ with organ cavity which is continuous superiorly with the pharynx and inferiorly with the stomach. Examples: There is only one esophagus.</Definition>
        <Definition>The tissue of the esophageal wall. It is composed of mucosa, a muscular coat, and a serosal surface. (NCI)</Definition>
        <Definition>Pathological processes in the ESOPHAGUS.</Definition>
        <Definition>The tissue of the esophageal wall. It is composed of mucosa, a muscular coat, and a serosal surface.</Definition>
        <Definition>The muscular membranous segment between the PHARYNX and the STOMACH in the UPPER GASTROINTESTINAL TRACT.</Definition>
        <Definition>Organ with organ cavity which is continuous superiorly with the pharynx and inferiorly with the stomach. [FMA]</Definition>
        <Definition>portion of the digestive canal between the pharynx and stomach.</Definition>
        <Definition>&lt;p&gt;The esophagus is the tube that carries food, liquids and saliva from your mouth to the stomach. You may not be aware of your esophagus until you swallow something too large, too hot or too cold. You may also become aware of it when something is wrong. &lt;/p&gt;&lt;p&gt;The most common problem with the esophagus is &lt;a href='http://www.nlm.nih.gov/medlineplus/gerd.html'&gt;gastroesophageal reflux disease&lt;/a&gt; (GERD). It happens when a band of muscle at the end of your esophagus does not close properly. This allows stomach contents to leak back, or reflux, into the esophagus and irritate it. Over time, GERD can cause damage to the esophagus. Other problems include &lt;a href='http://www.nlm.nih.gov/medlineplus/heartburn.html'&gt;heartburn&lt;/a&gt; and &lt;a href='http://www.nlm.nih.gov/medlineplus/cancer.html'&gt;cancer&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;Treatment depends on the problem. Some get better with over-the-counter medicines or changes in diet. Others may need prescription medicines or surgery. &lt;/p&gt;</Definition>
        <Definition>A non-neoplastic or neoplastic disorder that affects the esophagus. Representative examples of non-neoplastic disorders include esophagitis and esophageal ulcer. Representative examples of neoplastic disorders include carcinomas, lymphomas, and melanomas.</Definition>
        <Definition>The portion of the digestive canal between the pharynx and stomach. It is about 25 cm long and consists of three parts: the cervical part, from the cricoid cartilage to the thoracic inlet; thoracic part, from thoracic inlet to the diaphragm; and abdominal part, below the diaphragm to the cardiac opening of the stomach.</Definition>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <SemanticType code="T033" name="Finding"/>
        <SemanticType code="T047" name="Disease or Syndrome"/>
        <SemanticType code="T024" name="Tissue"/>
        <Source name="NMVB"/>
        <Term preferred="true">Esophagus</Term>
        <Term>Oesophageal structure</Term>
        <Term>esophagus disorder</Term>
        <Term>Esophagus normal</Term>
        <Term>ESOPHAGEAL DIS</Term>
        <Term>Disease of esophagus, unspecified</Term>
        <Term>Gullet</Term>
        <Term>Esophageal Disorder</Term>
        <Term>Esophageal disorder NOS</Term>
        <Term>Disorder of oesophagus</Term>
        <Term>Esophageal Tissue</Term>
        <Term>DISEASES OF ESOPHAGUS</Term>
        <Term>Oesophageal disorder</Term>
        <Term>Gastrointestinal Tract, Esophagus</Term>
        <Term>Esophageal disease NOS</Term>
        <Term>Esophagus, NOS</Term>
        <Term>Disorder of esophagus (disorder)</Term>
        <Term>Esophageal structure (body structure)</Term>
        <Term>Oesophagus normal</Term>
        <Term>Disease of oesophagus, unspecified</Term>
        <Term>Unspecified disorder of oesophagus</Term>
        <Term>Disease, Esophageal</Term>
        <Term>Disease of esophagus</Term>
        <Term>Oesophageal disorder NOS</Term>
        <Term>Esophageal structure</Term>
        <Term>Esophageal disorder</Term>
        <Term>ESOPHAGUS</Term>
        <Term>Unspecified disorder of esophagus</Term>
        <Term>Esophagus Disorders</Term>
        <Term>Oesophagus</Term>
        <Term>Esophageal Diseases</Term>
        <Term>Esophageal Diseases [Disease/Finding]</Term>
        <Term>Diseases of esophagus</Term>
        <Term>esophagus</Term>
        <Term>Oesophageal disease NOS</Term>
        <Term>ESOPHAGEAL DISORDER</Term>
        <Term>Entire esophagus (body structure)</Term>
        <Term>Entire esophagus</Term>
        <Term>Esophageal Disease</Term>
        <Term>Disorder of esophagus</Term>
        <Term>ESOPHAGEAL</Term>
        <Term>esophageal disorder</Term>
        <Term>DISEASES OF OESOPHAGUS</Term>
        <Term>Entire oesophagus</Term>
        <Term>Diseases, Esophageal</Term>
        <Term>Esophagus normal (finding)</Term>
        <Term>Esophageal disorders</Term>
        <Term>esoph</Term>
        <Codes>
          <Code code="C1278919" source="C1278919"/>
          <Code code="300294009" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Rectum" name="Rectum">
        <Definition>A primary or metastatic malignant neoplasm that affects the rectum. Representative examples include carcinoma, lymphoma, and sarcoma.</Definition>
        <Definition>&lt;p&gt;The rectum is the lower part of your large intestine where your body stores stool. Problems with rectum are common. They include &lt;a href='http://www.nlm.nih.gov/medlineplus/hemorrhoids.html'&gt;hemorrhoids&lt;/a&gt;, abscesses, &lt;a href='http://www.nlm.nih.gov/medlineplus/bowelincontinence.html'&gt;incontinence&lt;/a&gt; and &lt;a href='http://www.nlm.nih.gov/medlineplus/colorectalcancer.html'&gt;cancer&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;Many people are embarrassed to talk about rectal troubles. But seeing your doctor about problems in this area is important. This is especially true if you have pain or bleeding. Treatments vary widely depending on the particular problem.&lt;/p&gt;&lt;p &gt;NIH: National Institute of Diabetes and Digestive and Kidney Diseases&lt;/p&gt;</Definition>
        <Definition>The terminal portion of the gastrointestinal tract, extending from the rectosigmoid junction to the anal canal.</Definition>
        <Definition>The terminal portion of the gastrointestinal tract, extending from the rectosigmoid junction to the anal canal. (NCI)</Definition>
        <Definition>Pathological developments in the RECTUM region of the large intestine (INTESTINE, LARGE).</Definition>
        <Definition>The last several inches of the large intestine closest to the anus.</Definition>
        <Definition>The distal segment of the LARGE INTESTINE, between the SIGMOID COLON and the ANAL CANAL.</Definition>
        <Definition>The distal segment of the large intestine, between the sigmoid colon and the anal canal. [MeSH]</Definition>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <SemanticType code="T191" name="Neoplastic Process"/>
        <SemanticType code="T047" name="Disease or Syndrome"/>
        <Source name="NMVB"/>
        <Term preferred="true">Rectum</Term>
        <Term>RECTAL DISORDER</Term>
        <Term>Malignant Neoplasm of Rectum</Term>
        <Term>Disorder of rectum</Term>
        <Term>Rectum Cancer</Term>
        <Term>Cancer of Rectum</Term>
        <Term>Rectum Cancers</Term>
        <Term>Malignant tumor of rectum (disorder)</Term>
        <Term>Hemorrhoidal</Term>
        <Term>Rectal Disease</Term>
        <Term>RECTUM</Term>
        <Term>Malignant neopl rectum</Term>
        <Term>Rectums</Term>
        <Term>Entire rectum</Term>
        <Term>Disorder of rectum (disorder)</Term>
        <Term>Cancers, Rectum</Term>
        <Term>Rectal cancer</Term>
        <Term>Cancer, Rectum</Term>
        <Term>Disease, Rectal</Term>
        <Term>Malignant Rectal Neoplasm</Term>
        <Term>Malignant neoplasm of rectum (C20)</Term>
        <Term>Diseases, Rectal</Term>
        <Term>Rectal Diseases [Disease/Finding]</Term>
        <Term>Rectal disorder</Term>
        <Term>rectum</Term>
        <Term>rectum cancer</Term>
        <Term>Malignant tumor of rectum</Term>
        <Term>Rectal Diseases</Term>
        <Term>Rectum structure</Term>
        <Term>DISORDER RECTAL</Term>
        <Term>CA - Cancer of rectum</Term>
        <Term>Rectal Cancer</Term>
        <Term>Cancer, Rectal</Term>
        <Term>Malignant tumour of rectum</Term>
        <Term>rectal disorder</Term>
        <Term>Rectum structure (body structure)</Term>
        <Term>Cancers, Rectal</Term>
        <Term>Rectum, NOS</Term>
        <Term>Malignant Neoplasm of the Rectum</Term>
        <Term>Rectal Cancers</Term>
        <Term>Entire rectum (body structure)</Term>
        <Term>Cancer of the Rectum</Term>
        <Term>Rectal disorder NOS</Term>
        <Term>Rectal Disorders</Term>
        <Term>Disorder rectal</Term>
        <Term>Malignant neoplasm of rectum</Term>
        <Term>Malignant Tumor of Rectum</Term>
        <Term>Malignant Tumor of the Rectum</Term>
        <Term>Malignant Rectal Tumor</Term>
        <Term>LARGE INTESTINE, RECTUM</Term>
        <Term>RECTAL DIS</Term>
        <Codes>
          <Code code="363351006" source="Code"/>
          <Code code="C1278926" source="C1278926"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Mixed_inflammation" name="Mixed inflammation">
        <SemanticType code="T033" name="Finding"/>
        <Source name="NMVB"/>
        <Term preferred="true">Mixed inflammation</Term>
        <Term>Moderate inflammation</Term>
        <Term>Moderate inflammation (morphologic abnormality)</Term>
        <Codes>
          <Code code="C0522568" source="Code"/>
          <Code code="103623002" source="103623002"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Additional_Pathologic_Findings</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:peritoneum" name="peritoneum">
        <Definition>Cancer of the tissue that lines the abdominal wall and covers organs in the abdomen.</Definition>
        <Definition>endothelial lining of the abdominal cavity.</Definition>
        <Definition>A membrane of squamous epithelial cells, the mesothelial cells, covered by apical microvilli that allow rapid absorption of fluid and particles in the peritoneal cavity. The peritoneum is divided into parietal and visceral components. The parietal peritoneum covers the inside of the abdominal wall. The visceral peritoneum covers the intraperitoneal organs. The double-layered peritoneum forms the mesentery that suspends these organs from the abdominal wall. [MeSH]</Definition>
        <Definition>The tissue that lines the abdominal wall and covers most of the organs in the abdomen.</Definition>
        <Definition>A membrane of squamous EPITHELIAL CELLS, the mesothelial cells, covered by apical MICROVILLI that allow rapid absorption of fluid and particles in the PERITONEAL CAVITY. The peritoneum is divided into parietal and visceral components. The parietal peritoneum covers the inside of the ABDOMINAL WALL. The visceral peritoneum covers the intraperitoneal organs. The double-layered peritoneum forms the MESENTERY that suspends these organs from the abdominal wall.</Definition>
        <Definition>A primary or metastatic malignant neoplasm involving the peritoneum. Representative examples include carcinoma and malignant mesothelioma.</Definition>
        <Definition>The tissue that lines the wall of the abdominal cavity, intestine, and mesentery. It consists of the parietal peritoneum that covers the inside of the abdominal wall and the visceral peritoneum that covers the surface of the intestine and mesentery. (NCI)</Definition>
        <Definition>The tissue that lines the wall of the abdominal cavity, intestine, and mesentery. It consists of the parietal peritoneum that covers the inside of the abdominal wall and the visceral peritoneum that covers the surface of the intestine and mesentery.</Definition>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <SemanticType code="T191" name="Neoplastic Process"/>
        <Source name="NMVB"/>
        <Term preferred="true">peritoneum</Term>
        <Term>Peritoneum, NOS</Term>
        <Term>Peritoneal cancer</Term>
        <Term>CA - Cancer of peritoneum</Term>
        <Term>perito</Term>
        <Term>Peritoneum (serous membrane) structure</Term>
        <Term>Cancer of peritoneum</Term>
        <Term>Malignant tumor of peritoneum (disorder)</Term>
        <Term>PERITONEUM</Term>
        <Term>Malignant tumour of peritoneum</Term>
        <Term>Peritoneum (serous membrane) structure (body structure)</Term>
        <Term>Wall of peritoneal sac</Term>
        <Term>Malignant tumor of peritoneum</Term>
        <Term>Serous membrane of abdomen</Term>
        <Term>Peritoneum</Term>
        <Codes>
          <Code code="363492001" source="363492001"/>
          <Code code="C0031153" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Ber-EP4" name="Ber-EP4">
        <Source name="NMVB"/>
        <Term preferred="true">Ber-EP4</Term>
        <Relations>
          <Relation name="Broader">NMVB:Immunohistochemical_Profile</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Anus" name="Anus">
        <Definition>&lt;p&gt;The anus is the opening of the rectum through which stool passes out of your body. Problems with the anus are common. They include &lt;a href='http://www.nlm.nih.gov/medlineplus/hemorrhoids.html'&gt;hemorrhoids&lt;/a&gt;, &lt;a href='http://www.nlm.nih.gov/medlineplus/abscess.html'&gt;abscesses&lt;/a&gt;, fissures (cracks), and &lt;a href='http://www.nlm.nih.gov/medlineplus/analcancer.html'&gt;cancer&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;Many people are embarrassed to talk about anal troubles. But seeing your doctor about problems in this area is important. This is especially true if you have pain or bleeding. Treatments vary widely depending on the particular problem.&lt;/p&gt;&lt;p &gt;NIH: National Institute of Diabetes and Digestive and Kidney Diseases &lt;/p&gt;</Definition>
        <Definition>The opening of the rectum to the outside of the body.</Definition>
        <Definition>The lower opening of the digestive tract, lying in the cleft between the buttocks, through which fecal matter is extruded.</Definition>
        <Definition>The external outlet of the GASTROINTESTINAL TRACT.</Definition>
        <Definition>The external outlet of the gastrointestinal tract. [MeSH]</Definition>
        <Definition>The lower opening of the digestive tract, lying in the cleft between the buttocks, through which fecal matter is extruded. (NCI)</Definition>
        <Definition>A non-neoplastic or neoplastic disorder that affects the anal canal or anal margin. Representative examples of non-neoplastic disorders include hemorrhoids and anal ulcer. Representative examples of neoplastic disorders include carcinoma, lymphoma, and melanoma.</Definition>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <SemanticType code="T047" name="Disease or Syndrome"/>
        <Source name="NMVB"/>
        <Term preferred="true">Anus</Term>
        <Term>Disease, Anus</Term>
        <Term>Anus Diseases</Term>
        <Term>ANUS DIS</Term>
        <Term>Anal</Term>
        <Term>Disorder of anus (disorder)</Term>
        <Term>Anus, NOS</Term>
        <Term>DISORDER ANUS</Term>
        <Term>ANUS DISORDER</Term>
        <Term>LARGE INTESTINE, ANUS</Term>
        <Term>Entire anus (body structure)</Term>
        <Term>Disorder anus</Term>
        <Term>Anal structure</Term>
        <Term>anus</Term>
        <Term>anal disorder</Term>
        <Term>ANUS</Term>
        <Term>Disorder of anus</Term>
        <Term>Entire anus</Term>
        <Term>Anal Disorders</Term>
        <Term>anal</Term>
        <Term>Anal structure (body structure)</Term>
        <Term>Anal disorder</Term>
        <Term>Diseases, Anus</Term>
        <Term>Anus Disease</Term>
        <Term>Anus disorder</Term>
        <Term>Anal disorder NOS</Term>
        <Term>Anal Disorder</Term>
        <Term>Anus Diseases [Disease/Finding]</Term>
        <Codes>
          <Code code="181262009" source="Code"/>
          <Code code="C1278927" source="C1278927"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Exophytic" name="Exophytic">
        <Definition>Growing outward; developing externally.</Definition>
        <SemanticType code="T033" name="Finding"/>
        <SemanticType code="T080" name="Qualitative Concept"/>
        <Source name="NMVB"/>
        <Term preferred="true">Exophytic</Term>
        <Term>Exophytic (polypoid) tumour configuration</Term>
        <Term>exophytic</Term>
        <Term>Exophytic (polypoid) tumor configuration</Term>
        <Term>Exophytic (polypoid) tumor configuration (finding)</Term>
        <Codes>
          <Code code="C2700034" source="Code"/>
          <Code code="369749000" source="369749000"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Configuration</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Rectosigmoid" name="Rectosigmoid">
        <Definition>A primary or metastatic malignant neoplasm that affects the rectosigmoid area. Representative examples include carcinoma, lymphoma, and sarcoma.</Definition>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <SemanticType code="T191" name="Neoplastic Process"/>
        <Source name="NMVB"/>
        <Term preferred="true">Rectosigmoid</Term>
        <Term>Rectum and sigmoid colon, CS</Term>
        <Term>Ca rectosigmoid junction</Term>
        <Term>Malignant tumour of rectosigmoid junction</Term>
        <Term>Rectosigmoid structure</Term>
        <Term>Rectosigmoid, NOS</Term>
        <Term>Rectosigmoid structure (body structure)</Term>
        <Term>Rectum and sigmoid colon</Term>
        <Term>Malignant tumor of rectosigmoid junction</Term>
        <Term>Malignant tumor of rectosigmoid junction (disorder)</Term>
        <Codes>
          <Code code="363414004" source="363414004"/>
          <Code code="C0521377" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Papillary" name="Papillary">
        <Definition>Of or relating to or resembling papilla.</Definition>
        <SemanticType code="T080" name="Qualitative Concept"/>
        <Source name="NMVB"/>
        <Term preferred="true">Papillary</Term>
        <Term>Papillary (qualifier value)</Term>
        <Codes>
          <Code code="C0205312" source="C0205312"/>
          <Code code="77526009" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Configuration</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Leukemia" name="Leukemia">
        <Source name="NMVB"/>
        <Term preferred="true">Leukemia</Term>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:chronic_inflammation" name="chronic inflammation">
        <SemanticType code="T046" name="Pathologic Function"/>
        <Source name="NMVB"/>
        <Term preferred="true">chronic inflammation</Term>
        <Term>Chronic inflammation</Term>
        <Term>Chronic inflammatory reaction</Term>
        <Term>Chronic inflammatory cell infiltration</Term>
        <Term>Chronic inflammation (morphologic abnormality)</Term>
        <Codes>
          <Code code="84499006" source="84499006"/>
          <Code code="C0021376" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Additional_Pathologic_Findings</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Renal_Pelvis" name="Renal Pelvis">
        <Definition>The funnel-shaped proximal portion of the ureter located within the kidney into which urine is secreted, from the collecting duct system of the kidney.</Definition>
        <Definition>The area at the center of the kidney. Urine collects here and is funneled into the ureter, the tube that connects the kidney to the bladder.</Definition>
        <Definition>The flattened, funnel-shaped expansion connecting the URETER to the KIDNEY CALICES.</Definition>
        <Definition>A primary or metastatic malignant neoplasm that affects the renal pelvis.</Definition>
        <Definition>The flattened, funnel-shaped expansion connecting the ureter to the kidney calices. [MeSH]</Definition>
        <Definition>The funnel-shaped proximal portion of the ureter located within the kidney into which urine is secreted, from the collecting duct system of the kidney. (NCI)</Definition>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <SemanticType code="T191" name="Neoplastic Process"/>
        <Source name="NMVB"/>
        <Term preferred="true">Renal Pelvis</Term>
        <Term>Pelvis, Kidney</Term>
        <Term>Kidney Pelvis</Term>
        <Term>Pelvis, Renal</Term>
        <Term>Malignant tumor of renal pelvis (disorder)</Term>
        <Term>Renal pelvis structure (body structure)</Term>
        <Term>Pelvis of kidney</Term>
        <Term>RENAL PELVIS</Term>
        <Term>Renal pelvis structure</Term>
        <Term>Renal pelvis</Term>
        <Term>Malignant tumour of renal pelvis</Term>
        <Term>Kidney/Renal Pelvis (Other and Unspecified Urinary Organs)</Term>
        <Term>renal pelvis</Term>
        <Term>Malignant tumor of renal pelvis</Term>
        <Term>Pelvis of ureter</Term>
        <Term>Pelvis renalis</Term>
        <Term>OTHER AND UNSPECIFIED URINARY ORGANS</Term>
        <Codes>
          <Code code="C0227666" source="C0227666"/>
          <Code code="363457009" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:pelvic_peritoneum" name="pelvic peritoneum">
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <Source name="NMVB"/>
        <Term preferred="true">pelvic peritoneum</Term>
        <Term>Pelvic part of peritoneum</Term>
        <Term>Pelvic peritoneum structure (body structure)</Term>
        <Term>Pelvic peritoneal structure</Term>
        <Term>Entire pelvic peritoneum (body structure)</Term>
        <Term>Entire pelvic peritoneum</Term>
        <Term>Pelvic peritoneum structure</Term>
        <Term>Pelvic peritoneum</Term>
        <Codes>
          <Code code="362721006" source="Code"/>
          <Code code="C0230295" source="C0230295"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Negative_for_mesothelioma" name="negative">
        <Source name="NMVB"/>
        <Term preferred="true">negative</Term>
        <Term>Negative for mesothelioma</Term>
        <Term>uninvolved</Term>
        <Term form="RegEx">free of</Term>
        <Term form="RegEx">not involved</Term>
        <Term>clear</Term>
        <Relations>
          <Relation name="Broader">NMVB:Surgical_Margins_Modifiers</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:pericardium" name="pericardium">
        <Definition>Serous sac, which has as parts the serous pericardium and the pericardial cavity . Examples: There is only one pericardial sac.</Definition>
        <Definition>A conical membranous sac filled with serous fluid in which the heart as well as the roots of the aorta and other large blood vessels are contained. (NCI)</Definition>
        <Definition>membranous sac that envelops the heart and the roots of the great vessels.</Definition>
        <Definition>A conical membranous sac filled with serous fluid in which the heart as well as the roots of the aorta and other large blood vessels are contained.</Definition>
        <Definition>A conical fibro-serous sac surrounding the heart and the roots of the great vessels (aorta; venae cavae; pulmonary artery). The pericardium consists of two layers or sacs, the outer fibrous pericardium and the inner serous pericardium (or epicardium). [MeSH]</Definition>
        <Definition>Organ cluster which has as its parts the fibrous pericardium and the pericardial sac.</Definition>
        <Definition>Serous sac that surrounds the heart. Examples: There is only one pericardial sac.</Definition>
        <Definition>A conical fibro-serous sac surrounding the HEART and the roots of the great vessels (AORTA; VENAE CAVAE; PULMONARY ARTERY). Pericardium consists of two sacs, the outer fibrous pericardium and the inner serous pericardium. The latter consists of an outer parietal layer facing the fibrous pericardium, and an inner visceral layer (epicardium) resting next to the heart, and a pericardial cavity between these two layers.</Definition>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <Source name="NMVB"/>
        <Term preferred="true">pericardium</Term>
        <Term>Entire pericardium (body structure)</Term>
        <Term>Pericardial sac</Term>
        <Term>PERICARDIUM</Term>
        <Term>Pericardial sac structure (body structure)</Term>
        <Term>Pericardial sac structure</Term>
        <Term>Pericardial structure</Term>
        <Term>Pericardial structure (body structure)</Term>
        <Term>Entire pericardium</Term>
        <Term>Pericardium</Term>
        <Codes>
          <Code code="181295003" source="181295003"/>
          <Code code="C1278933" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:D2-40" name="D2-40">
        <Source name="NMVB"/>
        <Term preferred="true">D2-40</Term>
        <Relations>
          <Relation name="Broader">NMVB:Immunohistochemical_Profile</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Thyroid" name="Thyroid">
        <Definition>A benign or malignant neoplasm affecting the thyroid gland.</Definition>
        <Definition>Tumors or cancer of the THYROID GLAND.</Definition>
        <Definition>A highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the trachea. It secretes thyroid hormones from the follicular cells and calcitonin from the parafollicular cells thereby regulating metabolism and calcium level in blood, respectively. [MeSH]</Definition>
        <Definition>An endocrine gland located at the base of the neck that produces and secretes thyroxine and other hormones. Thyroxine is important for metabolic control. (NCI)</Definition>
        <Definition>endocrine gland normally situated in the lower part of the front of the neck; secretes, stores and releases the iodine dependent thyroid hormones thyroxine and triiodothyroine which play major endocrine roles in regulating metabolic rate; also secretes thyrocalcitonin.</Definition>
        <Definition>A dehydrated extract of thyroid glands from domesticated animals. After the removal of fat and connective tissue, the extract is dried or lyophilized to yield a yellowish to buff-colored amorphous powder containing 0.17-0.23% of iodine.</Definition>
        <Definition>Compounds that influence the function of the thyroid hormone through replacement, inhibition or stimulation. (NCI)</Definition>
        <Definition>&lt;p&gt;Your thyroid is a butterfly-shaped gland in your neck, just above your collarbone. It is one of your endocrine glands, which make hormones. Thyroid hormones control the rate of many activities in your body. These include how fast you burn calories and how fast your heart beats. All of these activities are your body's metabolism.&lt;/p&gt;&lt;p&gt;If your thyroid gland is not active enough, it is called hypothyroidism. It can make you gain weight, feel fatigued, and have difficulty dealing with cold temperatures.&lt;/p&gt;&lt;p&gt;If your thyroid is too active, it makes more thyroid hormones than your body needs. That condition is called hyperthyroidism. Too much thyroid hormone can make you lose weight, speed up your heart rate, and make you very sensitive to heat.&lt;/p&gt;&lt;p&gt;There are many causes for both conditions. Treatment involves trying to reset your body's metabolism to a normal rate.&lt;/p&gt;&lt;p&gt;The thyroid gland can also develop cancer. &lt;/p&gt;&lt;p &gt;Dept. of Health and Human Services Office on Women's Health&lt;/p&gt;</Definition>
        <Definition>Pathological processes involving the THYROID GLAND.</Definition>
        <Definition>A highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the TRACHEA. It secretes THYROID HORMONES from the follicular cells and CALCITONIN from the parafollicular cells thereby regulating METABOLISM and CALCIUM level in blood, respectively.</Definition>
        <Definition>A non-neoplastic or neoplastic disorder that affects the thyroid gland. Representative examples include hyperthyroidism, hypothyroidism, thyroiditis, follicular adenoma, and carcinoma.</Definition>
        <Definition>A gland located beneath the larynx (voice box) that makes thyroid hormone and calcitonin. The thyroid gland helps regulate growth and metabolism.</Definition>
        <Definition>new abnormal thyroid tissue that grows by excessive cellular division and proliferation more rapidly than normal and continues to grow after the stimuli that initiated the new growth cease.</Definition>
        <Definition>condition in which there is a deviation from or interruption of the normal structure or function of the thyroid gland, which is a highly vascular endocrine gland that produces the thyroid hormones which are concerned in regulating the metabolic rate of the body.</Definition>
        <Definition>An endocrine gland located at the base of the neck that produces and secretes thyroxine and other hormones. Thyroxine is important for metabolic control.</Definition>
        <Definition>Lobular organ the parenchyma of which consists of ductless, glandular follicles filled with colloid. Examples: thyroid gland proper, accessory thyroid gland, lingual thyroid gland.</Definition>
        <SemanticType code="T109" name="Organic Chemical"/>
        <SemanticType code="T125" name="Hormone"/>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <SemanticType code="T191" name="Neoplastic Process"/>
        <SemanticType code="T047" name="Disease or Syndrome"/>
        <SemanticType code="T121" name="Pharmacologic Substance"/>
        <Source name="NMVB"/>
        <Term preferred="true">Thyroid</Term>
        <Term>Thyroid Gland</Term>
        <Term>Thyroid, NOS</Term>
        <Term>Neoplasm of thyroid gland (disorder)</Term>
        <Term>Desiccated Thyroid Gland</Term>
        <Term>Thyroid Extract, Desiccated</Term>
        <Term>Thyroid Agent</Term>
        <Term>Disorders of thyroid gland (E00-E07)</Term>
        <Term>Desiccated Thyroid Extract</Term>
        <Term>Thyroid Gland Disorder</Term>
        <Term>Thyroid Disease</Term>
        <Term>Thyroid drug</Term>
        <Term>Thyroid Gland Diseases</Term>
        <Term>Thyroid preparation</Term>
        <Term>Thyroid disease</Term>
        <Term>thyroid gland</Term>
        <Term>Disorder of thyroid, unspecified</Term>
        <Term>Head and Neck, Thyroid</Term>
        <Term>Thyroid preparations</Term>
        <Term>Disorder of thyroid gland</Term>
        <Term>Dried Thyroid Extract</Term>
        <Term>Thyroid Gland Disease</Term>
        <Term>DISORDERS OF THYROID GLAND</Term>
        <Term>Tumor of thyroid gland</Term>
        <Term>THYROID DISEASE</Term>
        <Term>Disorders of thyroid gland</Term>
        <Term>Diseases, Thyroid</Term>
        <Term>Thyroid structure</Term>
        <Term>DISORDER THYROID</Term>
        <Term>Disorder thyroid</Term>
        <Term>THYROID GLAND</Term>
        <Term>Thyroid gland</Term>
        <Term>THYROID DIS</Term>
        <Term>Glands, Thyroid</Term>
        <Term>THYROID</Term>
        <Term>Thyroid Diseases</Term>
        <Term>Thyroid tumor</Term>
        <Term>thyroid (USP)</Term>
        <Term>Thyroid disorder</Term>
        <Term>Thyroid Glands</Term>
        <Term>thyroid disorder</Term>
        <Term>Glandula thyroidea</Term>
        <Term>Thyroid structure (body structure)</Term>
        <Term>Thyroid disorders</Term>
        <Term>Thyroid preparation (product)</Term>
        <Term>Thyroids</Term>
        <Term>Thyroid Gland Disorders</Term>
        <Term>thyroid</Term>
        <Term>THYROID, UNSPECIFIED</Term>
        <Term>Unspecified disorder of thyroid</Term>
        <Term>Thyroid (USP)</Term>
        <Term>Thyroideum Siccatum</Term>
        <Term>Thyroid Powder</Term>
        <Term>Extract, Dried Thyroid</Term>
        <Term>Thyroid, Unspecified</Term>
        <Term>Thyroid (USP) [Chemical/Ingredient]</Term>
        <Term>Thyroid, Dried</Term>
        <Term>Thyroid disorder NOS</Term>
        <Term>Thyroid Gland, Desiccated</Term>
        <Term>Thyroid agent</Term>
        <Term>Tumour of thyroid gland</Term>
        <Term>Gland, Thyroid</Term>
        <Term>Thyroid Diseases [Disease/Finding]</Term>
        <Term>Thyroid gland disorders</Term>
        <Term>THYROID DISEASE, NOS</Term>
        <Term>Dessicated Thyroid Extract</Term>
        <Term>THYROID DISORDER</Term>
        <Term>Thyroid Extract, Dried</Term>
        <Term>Disease, Thyroid</Term>
        <Term>Thyroid tumour</Term>
        <Term>Neoplasm of thyroid gland</Term>
        <Term>Disorder of thyroid NOS</Term>
        <Term>Disorder of thyroid gland (disorder)</Term>
        <Term>Dried Thyroid</Term>
        <Codes>
          <Code code="C0279175" source="C0279175"/>
          <Code code="127018007" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:3D_tumor_size" name="3D tumor size">
        <Source name="NMVB"/>
        <Term form="RegEx">\d(\.\d)?\s+[Xx]\s+\d(\.\d)?\s+[Xx]\s+\d(\.\d)?\s+[CcMm]{2}</Term>
        <Term preferred="true">3D tumor size</Term>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Dimension</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Localized" name="Localized">
        <Definition>Restricted to the site of origin, without evidence of spread.</Definition>
        <SemanticType code="T082" name="Spatial Concept"/>
        <SemanticType code="T033" name="Finding"/>
        <Source name="NMVB"/>
        <Term preferred="true">Localized</Term>
        <Term>localized</Term>
        <Term>Limited area</Term>
        <Term>Diffuse tumor configuration (finding)</Term>
        <Term>Diffuse tumor configuration</Term>
        <Term>Localised</Term>
        <Term>Localized (qualifier value)</Term>
        <Term>Diffuse tumour configuration</Term>
        <Term>LOCALIZED</Term>
        <Codes>
          <Code code="C0392752" source="C0392752"/>
          <Code code="369747003" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Configuration</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Prostate" name="Prostate">
        <Definition>Pathological processes involving the PROSTATE or its component tissues.</Definition>
        <Definition>&lt;p&gt;The prostate is a gland. It helps make semen, the fluid that contains sperm. The prostate surrounds the tube that carries urine away from the bladder and out of the body. A young man's prostate is about the size of a walnut. It slowly grows larger with age. If it gets too large, it can cause problems. This is very common after age 50. The older men get, the more likely they are to have prostate trouble.&lt;/p&gt; &lt;p&gt;Some common problems are&lt;/p&gt;&lt;ul&gt;&lt;li&gt; Prostatitis - an infection, usually caused by bacteria&lt;/li&gt;&lt;li&gt; Benign prostatic hyperplasia, or BPH - an enlarged prostate, which may cause dribbling after urination or a need to go often, especially at night&lt;/li&gt;&lt;li&gt; &lt;a href='http://www.nlm.nih.gov/medlineplus/prostatecancer.html'&gt;Prostate cancer&lt;/a&gt; - a common cancer that responds best to treatment when detected early&lt;/li&gt;&lt;/ul&gt;&lt;p &gt;NIH: National Institute of Diabetes and Digestive and Kidney Diseases&lt;/p&gt;</Definition>
        <Definition>A non-neoplastic or neoplastic disorder that affects the prostate gland. Representative examples include prostatitis, prostatic intraepithelial neoplasia, and carcinoma.</Definition>
        <Definition>A gland in the male reproductive system. The prostate surrounds the part of the urethra (the tube that empties the bladder) just below the bladder, and produces a fluid that forms part of the semen.</Definition>
        <Definition>The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen.</Definition>
        <Definition>deviation from or interruption of the normal structure or function of the prostate.</Definition>
        <Definition>A gland in males that surrounds the neck of the URINARY BLADDER and the URETHRA. It secretes a substance that liquefies coagulated semen. It is situated in the pelvic cavity behind the lower part of the PUBIC SYMPHYSIS, above the deep layer of the triangular ligament, and rests upon the RECTUM.</Definition>
        <Definition>gland in males that surrounds the neck of the bladder and the urethra; it contributes to the seminal fluid, a secretion containing acid phosphatase, citric acid, and proteolytic enzymes that liquefies coagulated semen.</Definition>
        <Definition>Lobular organ the parenchyma of which has as its parts glandular acini which are continuous with the prostatic part of the urethra. Examples: There is only one prostate.</Definition>
        <Definition>A primary or metastatic malignant tumor involving the prostate gland. The vast majority are carcinomas.</Definition>
        <Definition>A gland in males that surrounds the neck of the bladder and the urethra. It secretes a substance that liquefies coagulated semen. It is situated in the pelvic cavity behind the lower part of the pubic symphysis, above the deep layer of the triangular ligament, and rests upon the rectum. [MeSH]</Definition>
        <Definition>The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen. (NCI)</Definition>
        <Definition>Lobular organ the parenchyma of which consists of glandular acini which communicate with the prostatic part of the urethra. Examples: There is only one prostate.</Definition>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <SemanticType code="T191" name="Neoplastic Process"/>
        <SemanticType code="T047" name="Disease or Syndrome"/>
        <Source name="NMVB"/>
        <Term preferred="true">Prostate</Term>
        <Term>PROSTATE GLAND</Term>
        <Term>Malignant tumor of prostate (disorder)</Term>
        <Term>Prostatic structure (body structure)</Term>
        <Term>Prostate Disorder</Term>
        <Term>Disorder of prostate (disorder)</Term>
        <Term>prostate gland</Term>
        <Term>Prostate Diseases</Term>
        <Term>Prostatic Diseases</Term>
        <Term>Prostatic Disease</Term>
        <Term>Prostatic Gland</Term>
        <Term>Entire prostate (body structure)</Term>
        <Term>Prostata (Glandula prostatica)</Term>
        <Term>Primary malignant neoplasm of prostate</Term>
        <Term>PROSTATIC DIS</Term>
        <Term>Prostatic disorder NOS</Term>
        <Term>Prostatic Diseases [Disease/Finding]</Term>
        <Term>Disease, Prostatic</Term>
        <Term>Malignant prostatic tumour</Term>
        <Term>Prostates</Term>
        <Term>Prostatic structure</Term>
        <Term>prostate disorder</Term>
        <Term>prostatic gland</Term>
        <Term>Entire prostate</Term>
        <Term>Prostate Gland</Term>
        <Term>Prostata</Term>
        <Term>prostate</Term>
        <Term>Genital System, Male, Prostate</Term>
        <Term>Diseases, Prostatic</Term>
        <Term>Malignant prostatic tumor</Term>
        <Term>Disorder of prostate</Term>
        <Term>Unspecified disorder of prostate</Term>
        <Term>Prostate Disease</Term>
        <Term>Malignant tumour of prostate</Term>
        <Term>PROSTATIC DISORDER</Term>
        <Term>Prostatic disorder</Term>
        <Term>Prostate gland</Term>
        <Term>Malignant tumor of prostate</Term>
        <Term>Primary malignant neoplasm of prostate (disorder)</Term>
        <Term>Prostate, NOS</Term>
        <Term>Disorder of prostate, unspecified</Term>
        <Codes>
          <Code code="399068003" source="399068003"/>
          <Code code="C1278980" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Histochemical_Special_Stain_Profile" name="Histochemical Special Stain Profile">
        <SemanticType code="T059" name="Laboratory Procedure"/>
        <Source name="NMVB"/>
        <Term preferred="true">Histochemical Special Stain Profile</Term>
        <Term>Histochemical stain with frozen section</Term>
        <Term>Histochemical stain with frozen section (procedure)</Term>
        <Codes>
          <Code code="43554009" source="43554009"/>
          <Code code="C0200825" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Terminology</Relation>
          <Relation name="Narrower">NMVB:FISH</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Epithelial_membrane_antigen" name="Epithelial membrane antigen (EMA)">
        <Source name="NMVB"/>
        <Term preferred="true">Epithelial membrane antigen (EMA)</Term>
        <Relations>
          <Relation name="Broader">NMVB:Immunohistochemical_Profile</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:CD10" name="CD10">
        <Definition>A measurement of the CD10 expressing cells per unit in a biological specimen.</Definition>
        <Definition>Neprilysin (750 aa, ~86 kDa) is encoded by the human MME gene. This protein is involved in the metabolism of biologically active peptides.</Definition>
        <Definition>This gene is involved in the inactivation of peptide hormones.</Definition>
        <Definition>Enzyme that is a major constituent of kidney brush-border membranes and is also present to a lesser degree in the brain and other tissues. It preferentially catalyzes cleavage at the amino group of hydrophobic residues of the B-chain of insulin as well as opioid peptides and other biologically active peptides. The enzyme is inhibited primarily by EDTA, phosphoramidon, and thiorphan and is reactivated by zinc. Neprilysin is identical to common acute lymphoblastic leukemia antigen (CALLA Antigen), an important marker in the diagnosis of human acute lymphocytic leukemia. There is no relationship with CALLA PLANT.</Definition>
        <Definition>Human MME wild-type allele is located within 3q25.1-q25.2 and is approximately 104 kb in length. This allele, which encodes neprilysin protein, plays a role in the destruction of polypeptides containing up to 30 amino acids. An allelic variant of the MME gene is associated with fetomaternal alloimmunisation with antenatal glomerulopathies and membranous glomerulonephritis (FMAIG) as well as with renal failure in early adulthood. The MME gene is also associated with susceptibility to late-onset Alzheimer's disease.</Definition>
        <Definition>The determination of the amount of CD10 expressing cells per unit present in a sample.</Definition>
        <SemanticType code="T028" name="Gene or Genome"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T059" name="Laboratory Procedure"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T126" name="Enzyme"/>
        <Source name="NMVB"/>
        <Term preferred="true">CD10</Term>
        <Term>Common acute lymphoblastic leukemia antigen</Term>
        <Term>Skin Fibroblast Elastase</Term>
        <Term>kidney brush border neutral peptidase</Term>
        <Term>CALLA Antigen</Term>
        <Term>CD10 - Cluster of differentiation antigen 10</Term>
        <Term>MEMBRANE METALLOENDOPEPTIDASE</Term>
        <Term>Membrane Metallo-Endopeptidase (Neutral Endopeptidase, Enkephalinase, CALLA, CD10) Gene</Term>
        <Term>Neprilysin [Chemical/Ingredient]</Term>
        <Term>Endopeptidase-24.11</Term>
        <Term>Metalloendopeptidase, Thermolysin-Like</Term>
        <Term>SFE</Term>
        <Term>C10</Term>
        <Term>enkephalinase</Term>
        <Term>Endopeptidase, Neutral</Term>
        <Term>Antigens, Leukemia, Common Acute Lymphoblastic</Term>
        <Term>Membrane Metallo Endopeptidase</Term>
        <Term>Lymphocyte antigen CD10 (substance)</Term>
        <Term>Kidney-Brush-Border Neutral Proteinase</Term>
        <Term>Dipeptidyl Carboxypeptidase, Enkephalin</Term>
        <Term>Antigen CD10</Term>
        <Term>NEP</Term>
        <Term>MME Gene</Term>
        <Term>cALLa</Term>
        <Term>Kidney Brush Border Neutral Proteinase</Term>
        <Term>COMMON ACUTE LYMPHOCYTIC LEUKEMIA ANTIGEN</Term>
        <Term>Common Acute Lymphoblastic Leukemia Antigens</Term>
        <Term>CD 010 ANTIGENS</Term>
        <Term>Neprilysin</Term>
        <Term>CALLA - Common acute lymphoblastic leukemia antigen</Term>
        <Term>neprilysin</Term>
        <Term>Kidney-brush-border neutral proteinase</Term>
        <Term>Enkephalinase-24.11</Term>
        <Term>MME</Term>
        <Term>Neutral Endopeptidase 24.11</Term>
        <Term>Membrane Metallo-Endopeptidase</Term>
        <Term>Antigen, CD10</Term>
        <Term>Atriopeptidase</Term>
        <Term>YGG Forming Enzyme</Term>
        <Term>CALLA - Common acute lymphoblastic leukaemia antigen</Term>
        <Term>neutral endopeptidase</Term>
        <Term>Metallo-Endopeptidase, Membrane</Term>
        <Term>Membrane Metalloendopeptidase</Term>
        <Term>ATRIOPEPTIDASE</Term>
        <Term>membrane metallo-endopeptidase</Term>
        <Term>membrane metallo-endopeptidase (neutral endopeptidase, enkephalinase, CALLA, CD10)</Term>
        <Term>Common ALL Antigen</Term>
        <Term>Enkephalin Dipeptidyl Carboxypeptidase</Term>
        <Term>Thermolysin Like Metalloendopeptidase</Term>
        <Term>Endopeptidase 24.11</Term>
        <Term>CALLAS</Term>
        <Term>CD10 Ag</Term>
        <Term>c-ALL - Common acute lymphoblastic leukaemia antigen</Term>
        <Term>Neutral endopeptidase</Term>
        <Term>Enkephalinase</Term>
        <Term>Enkephalinase 24.11</Term>
        <Term>Carboxypeptidase, Enkephalin Dipeptidyl</Term>
        <Term>CD10 Expressing Cell Count</Term>
        <Term>CD10 Antigen</Term>
        <Term>CD10 Antigens</Term>
        <Term>Membrane Metallo-Endopeptidase (Neutral Endopeptidase, Enkephalinase, CALLA, CD10) wt Allele</Term>
        <Term>Lymphocyte antigen CD10</Term>
        <Term>(gDNA).MME</Term>
        <Term>Cluster of differentiation antigen 10</Term>
        <Term>MME gene</Term>
        <Term>Enzyme, YGG-Forming</Term>
        <Term>EC 3.4.24.11</Term>
        <Term>YGG-Forming Enzyme</Term>
        <Term>Membrane metallo-endopeptidase</Term>
        <Term>ENKEPHALINASE</Term>
        <Term>Neutral Proteinase, Kidney-Brush-Border</Term>
        <Term>Common Acute Lymphoblastic Leukemia Antigen</Term>
        <Term>MME Expressing Cell Count</Term>
        <Term>(AA).MME.0</Term>
        <Term>Thermolysin-Like Metalloendopeptidase</Term>
        <Term>ANTIGENS CD 010</Term>
        <Term>NEUTRAL ENDOPEPTIDASE, MEMBRANE-ASSOCIATED</Term>
        <Term>Neutral Endopeptidase</Term>
        <Term>Neprilysin Expressing Cell Count</Term>
        <Term>CALLA</Term>
        <Term>c-ALL - Common acute lymphoblastic leukemia antigen</Term>
        <Term>Endopeptidase 24.11, Neutral</Term>
        <Term>Common acute lymphoblastic leukaemia antigen</Term>
        <Term>NEPRILYSIN</Term>
        <Term>Antigens, CD10</Term>
        <Term>MME wt Allele</Term>
        <Codes>
          <Code code="C1706431" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Immunohistochemical_Profile</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Histological_Type_Slot" name="Histological Type Slot">
        <Source name="NMVB"/>
        <Term preferred="true">Histological Type Slot</Term>
        <Relations>
          <Relation name="Broader">NMVB:Slot</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Attributes" name="Attributes">
        <Source name="NMVB"/>
        <Term preferred="true">Attributes</Term>
        <Relations>
          <Relation name="Broader">NMVB:Terminology</Relation>
          <Relation name="Narrower">NMVB:Differentiation_or_Grade, NMVB:Surgical_Margins_Modifiers, NMVB:Configuration</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Mesothelin" name="Mesothelin">
        <Definition>A protein found on the surface of certain types of normal cells and cancer cells. Mesothelin may help these cells stick together and send signals. A higher-than-normal amount of mesothelin is found on some cancer cells, including mesothelioma, pancreatic cancer, and ovarian cancer.</Definition>
        <Definition>Mesothelin (630 aa, ~69 kDa) is encoded by the human MSLN gene. This protein may play a role in cellular adhesion.</Definition>
        <Definition>This gene may be involved in cellular adhesion.</Definition>
        <SemanticType code="T028" name="Gene or Genome"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="NMVB"/>
        <Term preferred="true">Mesothelin</Term>
        <Term>CAK1 Antigen</Term>
        <Term>Megakaryocyte Potentiating Factor</Term>
        <Term>MPF</Term>
        <Term>SMR</Term>
        <Term>CAK1</Term>
        <Term>Pre-Pro-Megakaryocyte-Potentiating Factor</Term>
        <Term>SOLUBLE MPF/MESOTHELIN-RELATED PROTEIN</Term>
        <Term>Mesothelin Gene</Term>
        <Term>MSLN Gene</Term>
        <Term>MESOTHELIN</Term>
        <Term>mesothelin</Term>
        <Term>MEGAKARYOCYTE-POTENTIATING FACTOR</Term>
        <Term>MSLN gene</Term>
        <Term>ANTIGEN RECOGNIZED BY MONOCLONAL ANTIBODY K1</Term>
        <Term>megakaryocyte potentiating factor</Term>
        <Term>MSLN</Term>
        <Term>Soluble Mpf/Mesothelin-Related Protein</Term>
        <Codes>
          <Code code="C1334533" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Immunohistochemical_Profile</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Right_visceral_pleura" name="Right visceral pleura">
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <Source name="NMVB"/>
        <Term preferred="true">Right visceral pleura</Term>
        <Term>Structure of right visceral pleura (body structure)</Term>
        <Term>Entire right visceral pleura</Term>
        <Term>Structure of right visceral pleura</Term>
        <Term>Entire right visceral pleura (body structure)</Term>
        <Codes>
          <Code code="184204006" source="184204006"/>
          <Code code="C1279203" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Low" name="Low">
        <Definition>An index used in neuroblastic tumors indicating the presence of less than 100 mitoses and karyorrhexis per 5,000 cells.</Definition>
        <Definition>&lt;p&gt;&lt;b&gt;Description:&lt;/b&gt;Exposure to an agent at a relatively low level above background.&lt;/p&gt;</Definition>
        <Definition>&lt;p&gt;Indicates the condition may result in some adverse consequences but is unlikely to substantially affect the situation of the subject.&lt;/p&gt;</Definition>
        <Definition>&lt;p&gt;Low priority messages are available&lt;/p&gt;</Definition>
        <Definition>A minimum level or position or degree; less than normal in degree, intensity or amount.</Definition>
        <Definition>&lt;p&gt;Indicates the highest importance level of the set of messages the acknowledging application has waiting on a queue for the receiving application.&lt;/p&gt;&lt;p&gt;&lt;i&gt;Discussion:&lt;/i&gt; These messages would need to be retrieved via a query. This facilitates receiving applications that cannot receive unsolicited messages (i.e. polling). The specific code specified identifies how important the most important waiting message is (and may govern how soon the receiving application is required to poll for the message).&lt;/p&gt;&lt;p&gt;Priority may be used by local agreement to determine the timeframe in which the receiving application is expected to retrieve the messages from the queue.&lt;/p&gt;</Definition>
        <Definition>&lt;p&gt;Below low normal (for quantitative observations)&lt;/p&gt;</Definition>
        <Definition>&lt;p&gt;Indicates that the receiver has messages for the sender&lt;/p&gt;&lt;p&gt;&lt;i&gt;OpenIssue:&lt;/i&gt;Description does not make sense relative to name of coding system. Must be reviewed and improved.&lt;/p&gt;</Definition>
        <Definition>&lt;p&gt;No patient record item can be of low confidentiality. However, some service objects are not patient related and therefore may have low confidentiality.&lt;/p&gt;</Definition>
        <SemanticType code="T078" name="Idea or Concept"/>
        <SemanticType code="T170" name="Intellectual Product"/>
        <SemanticType code="T033" name="Finding"/>
        <SemanticType code="T080" name="Qualitative Concept"/>
        <SemanticType code="T081" name="Quantitative Concept"/>
        <Source name="NMVB"/>
        <Term preferred="true">Low</Term>
        <Term>Abnormally low (qualifier value)</Term>
        <Term>Abnormally low</Term>
        <Term>Low Mitosis-Karyorrhexis Index</Term>
        <Term>MessageWaitingPriority</Term>
        <Term>Low - MessageWaitingPriority</Term>
        <Term>Low - observation</Term>
        <Term>Low grade histologic differentiation</Term>
        <Term>low confidentiality</Term>
        <Term>low</Term>
        <Term>Low grade histologic differentiation (finding)</Term>
        <Term>Low (qualifier value)</Term>
        <Codes>
          <Code code="CL480872" source="CL480872"/>
          <Code code="399415002" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Differentiation_or_Grade</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Desmoplastic_mesothelioma" name="Desmoplastic mesothelioma">
        <Definition>A malignant neoplasm arising from mesothelial cells. It is characterized by the presence of a dense collagenous tissue and atypical neoplastic cells. Sarcomatoid features, collagenous necrosis, and infiltration of muscle and adipose tissue may be present. It occurs in the pleura and less commonly in the peritoneum.</Definition>
        <SemanticType code="T191" name="Neoplastic Process"/>
        <Source name="NMVB"/>
        <Term preferred="true">Desmoplastic mesothelioma</Term>
        <Term>Desmoplastic Mesothelioma</Term>
        <Term>Desmoplastic mesothelioma (morphologic abnormality)</Term>
        <Codes>
          <Code code="C1270206" source="C1270206"/>
          <Code code="388650006" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Histological_Type</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Immunohistochemical_Profile" name="Immunohistochemical Profile">
        <Source name="NMVB"/>
        <Term preferred="true">Immunohistochemical Profile</Term>
        <Relations>
          <Relation name="Broader">NMVB:Terminology</Relation>
          <Relation name="Narrower">NMVB:E-cadherin, NMVB:TTF, NMVB:CK20, NMVB:Epithelial_membrane_antigen, NMVB:AE1_3, NMVB:N-cadherin, NMVB:CD44S, NMVB:HBME-1, NMVB:CD10, NMVB:TAG-72, NMVB:CAE, NMVB:Vimentin, NMVB:CD31, NMVB:CK5_6, NMVB:Thrombomodulin, NMVB:PSAD, NMVB:WT1, NMVB:CK7, NMVB:LeuM1, NMVB:D2-40, NMVB:Mesothelin, NMVB:Ber-EP4, NMVB:Calretinin</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Parotid_Other_Glands" name="Parotid &amp; Other Glands">
        <Source name="NMVB"/>
        <Term preferred="true">Parotid &amp; Other Glands</Term>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:TTF" name="TTF">
        <Definition>This gene plays a role in signal transduction in hematopoietic cells.</Definition>
        <Definition>Human RHOH wild-type allele is located in the vicinity of 4p13 and is approximately 48 kb in length. This allele, which encodes Rho-related GTP-binding protein RhoH, is involved in leukocyte adhesion attenuation. The gene is involved in a translocation t(3;4)(q27;p11) with the BCL6 gene in non-Hodgkin lymphoma patients. (SwissProt)</Definition>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="NMVB"/>
        <Term preferred="true">TTF</Term>
        <Term>(gDNA).RHOH</Term>
        <Term>RAS Homolog Gene Family, Member H wt Allele</Term>
        <Term>ras homolog family member H</Term>
        <Term>RhoH</Term>
        <Term>RAS HOMOLOG GENE FAMILY, MEMBER H</Term>
        <Term>RHOH wt Allele</Term>
        <Term>RHOH</Term>
        <Term>TRANSLOCATION THREE FOUR</Term>
        <Term>RAS Homolog Gene Family, Member H Gene</Term>
        <Term>ras homolog gene family, member H</Term>
        <Term>RHOH gene</Term>
        <Term>ARHH</Term>
        <Term>RHOH Gene</Term>
        <Codes>
          <Code code="C1705840" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Immunohistochemical_Profile</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Larynx" name="Larynx">
        <Definition>condition in which there is a deviation from or interruption of the normal structure or function of the larynx.</Definition>
        <Definition>The cartilaginous structure of the respiratory tract between the pharynx and the trachea. It contains elastic vocal cords required for sound production. (NCI)</Definition>
        <Definition>The cartilaginous structure of the respiratory tract between the pharynx and the trachea. It contains elastic vocal cords required for sound production.</Definition>
        <Definition>An irregularly shaped, musculocartilaginous tubular structure, lined with mucous membrane, located at the top of the trachea and below the root of the tongue and the hyoid bone. It is the essential sphincter guarding the entrance into the trachea and functioning secondarily as the organ of voice. [MeSH]</Definition>
        <Definition>Pathological processes involving any part of the LARYNX which coordinates many functions such as voice production, breathing, swallowing, and coughing.</Definition>
        <Definition>The area of the throat containing the vocal cords and used for breathing, swallowing, and talking.</Definition>
        <Definition>Heterogeneous cluster that connects the pharynx to the tracheobronchial tree. Examples: There is only one larynx.</Definition>
        <Definition>A tubular organ of VOICE production. It is located in the anterior neck, superior to the TRACHEA and inferior to the tongue and HYOID BONE.</Definition>
        <Definition>A non-neoplastic or neoplastic disorder that affects the larynx. Representative examples include laryngitis, vocal cord polyp, squamous papilloma, and carcinoma.</Definition>
        <Definition>irregularly shaped, musculocartilaginous tubular structure, lined with mucous membrane, located at the top of the trachea and below the root of the tongue and the hyoid bone; the essential sphincter guarding the entrance into the trachea and functioning secondarily as the organ of voice.</Definition>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <SemanticType code="T033" name="Finding"/>
        <SemanticType code="T047" name="Disease or Syndrome"/>
        <Source name="NMVB"/>
        <Term preferred="true">Larynx</Term>
        <Term>Larynx Disease</Term>
        <Term>Entire larynx</Term>
        <Term>Larynx structure</Term>
        <Term>Laryngeal Disease</Term>
        <Term>voicebox</Term>
        <Term>Laryngeal</Term>
        <Term>Laryngeal disorder NOS</Term>
        <Term>laryngeal disorder</Term>
        <Term>larynx</Term>
        <Term>Disease, Larynx</Term>
        <Term>Disorder of the larynx</Term>
        <Term>Diseases, Laryngeal</Term>
        <Term>Entire larynx (body structure)</Term>
        <Term>LARYNX</Term>
        <Term>voice box</Term>
        <Term>LARYNX DIS</Term>
        <Term>Larynx Diseases</Term>
        <Term>Laryngeal Disorder</Term>
        <Term>Larynx present (finding)</Term>
        <Term>Disorder of the larynx (disorder)</Term>
        <Term>LARYNGEAL DIS</Term>
        <Term>Laryngeal (qualifier value)</Term>
        <Term>Diseases, Larynx</Term>
        <Term>Larynx present</Term>
        <Term>Disease of larynx NOS</Term>
        <Term>Laryngeal Diseases [Disease/Finding]</Term>
        <Term>Laryngeal structure</Term>
        <Term>Unspecified disease of larynx</Term>
        <Term>laryngeal disease</Term>
        <Term>Disease of larynx</Term>
        <Term>Laryngeal Diseases</Term>
        <Term>Laryngeal disorder</Term>
        <Term>Disease, Laryngeal</Term>
        <Term>Disorder of larynx</Term>
        <Term>Head and Neck, Larynx</Term>
        <Term>Laryngeal structure (body structure)</Term>
        <Term>Larynx, NOS</Term>
        <Term>larynx disorder</Term>
        <Codes>
          <Code code="301207000" source="301207000"/>
          <Code code="C1278904" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Ureter" name="Ureter">
        <Definition>Administration of a drug into the ureter.</Definition>
        <Definition>The tube that carries urine from the kidney to the bladder.</Definition>
        <Definition>Administration into the ureter. (FDA)</Definition>
        <Definition>&lt;p&gt;Ureteral&lt;/p&gt;</Definition>
        <Definition>A primary or metastatic malignant tumor involving the ureter. The majority are carcinomas. -- 2003</Definition>
        <Definition>administration into the ureter.</Definition>
        <Definition>One of a pair of thick-walled tubes that transports urine from the KIDNEY PELVIS to the URINARY BLADDER.</Definition>
        <Definition>A non-neoplastic or neoplastic disorder affecting the ureter.</Definition>
        <Definition>Organ with organ cavity which connects the renal sinus to the urinary bladder. Examples: There are only two ureters, the right and the left ureters.</Definition>
        <Definition>The thick-walled tube that carries urine from each kidney to the bladder. (NCI)</Definition>
        <Definition>fibromuscular tube which conveys urine from the kidney to the bladder.</Definition>
        <Definition>A route that begins within a ureter.</Definition>
        <Definition>The thick-walled tube that carries urine from each kidney to the bladder.</Definition>
        <Definition>Organ with organ cavity which connects the renal sinus to the urinary bladder. Examples: There are only two ureters, the right and the left ureters. [FMA]</Definition>
        <SemanticType code="T169" name="Functional Concept"/>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <SemanticType code="T047" name="Disease or Syndrome"/>
        <SemanticType code="T191" name="Neoplastic Process"/>
        <Source name="NMVB"/>
        <Term preferred="true">Ureter</Term>
        <Term>Ureteral use</Term>
        <Term>Ureteral Route of Administration</Term>
        <Term>Ureter Disease</Term>
        <Term>Disorder of ureter (disorder)</Term>
        <Term>Malignant tumor of ureter (disorder)</Term>
        <Term>Ureteral route (qualifier value)</Term>
        <Term>Ureteral</Term>
        <Term>ureter</Term>
        <Term>URETERAL</Term>
        <Term>URETER</Term>
        <Term>Malignant tumour of ureter</Term>
        <Term>Cancer of ureter</Term>
        <Term>Disorder of ureter</Term>
        <Term>Ureteral Route of Drug Administration</Term>
        <Term>Ureter Ca</Term>
        <Term>ureteral</Term>
        <Term>Ureteric structure (body structure)</Term>
        <Term>Ureters</Term>
        <Term>Malignant tumor of ureter</Term>
        <Term>ureter(o)-</Term>
        <Term>Ureteric structure</Term>
        <Term>Ureteric Disorder</Term>
        <Term>Entire ureter</Term>
        <Term>Entire ureter (body structure)</Term>
        <Term>Ureteric</Term>
        <Term>Ureteral route</Term>
        <Term>UreteralRoute</Term>
        <Term>Ureteric Disease</Term>
        <Term>Ureter Disorder</Term>
        <Term>Ureteric (qualifier value)</Term>
        <Term>Ureteric disorders</Term>
        <Codes>
          <Code code="363458004" source="363458004"/>
          <Code code="C1281572" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Right_parietal_pleura" name="Right parietal pleura">
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <Source name="NMVB"/>
        <Term preferred="true">Right parietal pleura</Term>
        <Term>Entire right parietal pleura (body structure)</Term>
        <Term>Structure of right parietal pleura (body structure)</Term>
        <Term>Structure of right parietal pleura</Term>
        <Term>Entire right parietal pleura</Term>
        <Codes>
          <Code code="184304009" source="Code"/>
          <Code code="C1279204" source="C1279204"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Tumor_Dimension_Slot" name="Tumor Dimension Slot">
        <Source name="NMVB"/>
        <Term preferred="true">Tumor Dimension Slot</Term>
        <Relations>
          <Relation name="Broader">NMVB:Slot</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Ovary" name="Ovary">
        <Definition>The reproductive organ (gonads) in female animals. In vertebrates, the ovary contains two functional parts: the ovarian follicle for the production of female germ cells (oogenesis); and the endocrine cells (granulosa cells; theca cells; and luteal cells) for the production of estrogens and progesterone. [MeSH]</Definition>
        <Definition>The reproductive organ (GONADS) in female animals. In vertebrates, the ovary contains two functional parts: the OVARIAN FOLLICLE for the production of female germ cells (OOGENESIS); and the endocrine cells (GRANULOSA CELLS; THECA CELLS; and LUTEAL CELLS) for the production of ESTROGENS and PROGESTERONE.</Definition>
        <Definition>Cancer that forms in tissues of the ovary (one of a pair of female reproductive glands in which the ova, or eggs, are formed). Most ovarian cancers are either ovarian epithelial carcinomas (cancer that begins in the cells on the surface of the ovary) or malignant germ cell tumors (cancer that begins in egg cells).</Definition>
        <Definition>reproductive organ in female animals; in vertebrates, the ovary contains two functional parts, the ovarian follicle for the production of female germ cells (oogenesis); and the endocrine cells (granulosa cells, theca cells, and luteal cells) for the production of estrogens and progesterone.</Definition>
        <Definition>One of the paired female reproductive glands containing the ova or germ cells; the ovary's stroma is a vascular connective tissue containing numbers of ovarian follicles enclosing the ova. (NCI)</Definition>
        <Definition>&lt;p&gt;The ovaries are part of the female reproductive system. They produce a woman's eggs and female hormones. Each ovary is about the size and shape of an almond.&lt;/p&gt;&lt;p&gt;Cancer of the ovary is not common, but it causes more deaths than other female reproductive cancers. The sooner ovarian cancer is found and treated, the better your chance for recovery. But ovarian cancer is hard to detect early. Women with ovarian cancer may have no symptoms or just mild symptoms until the disease is in an advanced stage. Then it is hard to treat. Symptoms may include&lt;/p&gt;&lt;ul&gt; &lt;li&gt;A heavy feeling in the pelvis&lt;/li&gt; &lt;li&gt;Pain in the lower abdomen&lt;/li&gt; &lt;li&gt; Bleeding from the vagina&lt;/li&gt; &lt;li&gt; Weight gain or loss&lt;/li&gt; &lt;li&gt; Abnormal periods&lt;/li&gt; &lt;li&gt; Unexplained back pain that gets worse&lt;/li&gt; &lt;li&gt; Gas, nausea, vomiting, or loss of appetite&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;To diagnose ovarian cancer, doctors do one or more tests. They include a physical exam, a pelvic exam, lab tests, ultrasound, or a biopsy. Treatment is usually surgery followed by chemotherapy.&lt;/p&gt;&lt;p &gt;NIH: National Cancer Institute&lt;/p&gt;</Definition>
        <Definition>One of the paired female reproductive glands containing the ova or germ cells; the ovary's stroma is a vascular connective tissue containing numbers of ovarian follicles enclosing the ova.</Definition>
        <Definition>The pair of female reproductive glands in which the ova, or eggs, are formed. The ovaries are located in the pelvis, one on each side of the uterus.</Definition>
        <Definition>A primary or metastatic malignant neoplasm involving the ovary. Most primary malignant ovarian neoplasms are either carcinomas (serous, mucinous, or endometrioid adenocarcinomas) or malignant germ cell tumors. Metastatic malignant neoplasms to the ovary include carcinomas, lymphomas, and melanomas.</Definition>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <SemanticType code="T033" name="Finding"/>
        <SemanticType code="T191" name="Neoplastic Process"/>
        <Source name="NMVB"/>
        <Term preferred="true">Ovary</Term>
        <Term>Ovarian Ca</Term>
        <Term>female gonad</Term>
        <Term>Malignant tumor of ovary (disorder)</Term>
        <Term>Ovary (Other Uterine Adnexa)</Term>
        <Term>OVARY</Term>
        <Term>CA - Cancer of ovary</Term>
        <Term>Malignant tumor of ovary</Term>
        <Term>Entire ovary</Term>
        <Term>Ovarian structure</Term>
        <Term>Ovaries</Term>
        <Term>Cancer of ovary</Term>
        <Term>Genital System, Female, Ovary</Term>
        <Term>ovaries</Term>
        <Term>set of ovaries</Term>
        <Term>Entire ovary (body structure)</Term>
        <Term>Malignant tumour of ovary</Term>
        <Term>Ovarium</Term>
        <Term>Ovarian structure (body structure)</Term>
        <Term>ovary (excluding endocrine function)</Term>
        <Term>ovary</Term>
        <Term>OVARIAN DISORDERS</Term>
        <Term>Female gonad</Term>
        <Codes>
          <Code code="C1278992" source="C1278992"/>
          <Code code="363443007" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:WT1" name="WT1">
        <Definition>&lt;p&gt;Wilms' tumor is a rare type of kidney cancer. It causes a tumor on one or both kidneys. It usually affects children, but can happen in adults. Having certain genetic conditions or birth defects can increase the risk of getting it. Children that are at risk should be screened for Wilms' tumor every three months until they turn eight.&lt;/p&gt;&lt;p&gt;Symptoms include a lump in the abdomen, blood in the urine, and a fever for no reason. Tests that examine the kidney and blood are used to find the tumor.&lt;/p&gt;&lt;p&gt;Doctors usually diagnose and remove the tumor in surgery. Other treatments include chemotherapy and radiation and biologic therapies. Biologic therapy boosts your body's own ability to fight cancer.&lt;/p&gt;&lt;p &gt;NIH: National Cancer Institute&lt;/p&gt;</Definition>
        <Definition>A malignant embryonal neoplasm of the kidney.</Definition>
        <Definition>An embryonal pediatric tumor of the kidney which may also be seen rarely in adults. The peak incidence of Wilms tumor is between the second and fifth year of life. Microscopically, it is composed of a mixture of cellular elements (blastemal, stromal, and epithelial). The most common sites of metastasis include the regional lymph nodes, lungs, and liver.</Definition>
        <Definition>Isoforms encoded by the WT1 Wilms tumor suppressor gene (GENES, WILMS TUMOR) and produced by alternative splicings. They are zinc finger-containing transcription factors involved in both transactivation and repression, and are critical for normal development and function of the urogenital tract.</Definition>
        <Definition>A disease in which malignant (cancer) cells are found in the kidney, and may spread to the lungs, liver, or nearby lymph nodes. Wilms tumor usually occurs in children younger than 5 years old.</Definition>
        <Definition>Wilms tumor protein (449 aa, ~49 kDa) is encoded by the human WT1 gene. This protein is involved in transcriptional regulation, embryonic morphogenesis and in both tumor suppression and tumorigenesis.</Definition>
        <Definition>malignant kidney tumor made up of three cell types: blastemal, stromal, and epithelial, but not all present in every case.</Definition>
        <Definition>A malignant kidney tumor, caused by the uncontrolled multiplication of renal stem (blastemal), stromal (STROMAL CELLS), and epithelial (EPITHELIAL CELLS) elements. However, not all three are present in every case. Several genes or chromosomal areas have been associated with Wilms tumor which is usually found in childhood as a firm lump in a child's side or ABDOMEN.</Definition>
        <Definition>This gene may play a role in the regulation of gene expression.</Definition>
        <Definition>This gene plays a role in regulation of transcription. It is involved in the control of both cell differentiation and proliferation.</Definition>
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <SemanticType code="T191" name="Neoplastic Process"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="NMVB"/>
        <Term preferred="true">WT1</Term>
        <Term>Wilms tumour</Term>
        <Term>Nephroblastomas</Term>
        <Term>Tumor, Wilms'</Term>
        <Term>(gDNA).WT1</Term>
        <Term>WT1 Antisense RNA Gene</Term>
        <Term>KIDNEY, EMBRYOMA</Term>
        <Term>Wilms Tumor 1</Term>
        <Term>WT1 protein</Term>
        <Term>WT1-AS1</Term>
        <Term>Wilms tumor associated protein</Term>
        <Term>WT1 gene</Term>
        <Term>Wilms' tumour</Term>
        <Term>Tumor, Wilms</Term>
        <Term>Renal Wilms Tumor</Term>
        <Term>Nephroblastoma</Term>
        <Term>WT1 Protein</Term>
        <Term>Nephroblastoma, NOS</Term>
        <Term>WILMS TUMOR 1</Term>
        <Term>WT1 GENE</Term>
        <Term>Embryonal adenosarcoma</Term>
        <Term>Nephroblastoma (morphologic abnormality)</Term>
        <Term>Wilms Tumor of the Kidney</Term>
        <Term>WT1 antisense RNA</Term>
        <Term>Wilms Tumor [Disease/Finding]</Term>
        <Term>Renal adenosarcoma</Term>
        <Term>Proteins, WT1</Term>
        <Term>WIT-2</Term>
        <Term>Nephroma, NOS</Term>
        <Term>Nephroma</Term>
        <Term>Wilms Tumor Protein</Term>
        <Term>AWT1</Term>
        <Term>WIT1 GENE</Term>
        <Term>GUD</Term>
        <Term>nephroblastoma</Term>
        <Term>Wilm Tumor</Term>
        <Term>WT1 Gene Product</Term>
        <Term>Embryonal Nephroma</Term>
        <Term>KIDNEY, ADENOMYOSARCOMA, EMBRYONAL</Term>
        <Term>WIT-1</Term>
        <Term>WT1-AS</Term>
        <Term>WT33</Term>
        <Term>Gene Product, WT1</Term>
        <Term>WT PROTEINS 001</Term>
        <Term>Nephroblastoma (disorder)</Term>
        <Term>Wilms Tumor</Term>
        <Term>WAGR</Term>
        <Term>WT1-AS Gene</Term>
        <Term>NEPHROBLASTOMA</Term>
        <Term>Wilms' tumor</Term>
        <Term>RENAL CANCER, WILMS</Term>
        <Term>Nephroblastoma (Wilms tumor)</Term>
        <Term>Wilm's Tumor</Term>
        <Term>WT1-AS gene</Term>
        <Term>Wilms tumor</Term>
        <Term>KIDNEY, EMBRYONAL MIXED TUMOR</Term>
        <Term>WT1 Proteins</Term>
        <Term>NEPHROBLASTOMA, MALIGNANT</Term>
        <Term>Embryonal nephroma</Term>
        <Term>WT1 Gene</Term>
        <Term>WT1 Proteins [Chemical/Ingredient]</Term>
        <Term>Wilms tumor 1</Term>
        <Term>Wilms' Tumor</Term>
        <Term>Renal Wilms' Tumor</Term>
        <Term>Protein, WT1</Term>
        <Term>KIDNEY, CARCINOSARCOMA, EMBRYONAL</Term>
        <Term>Wilm's tumor</Term>
        <Term>WIT1</Term>
        <Term>Wilms' Tumor of the Kidney</Term>
        <Term>(AA).WT1.0</Term>
        <Term>WT1AS</Term>
        <Term>Wilms Tumor 1 Gene</Term>
        <Codes>
          <Code code="C1823861" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Immunohistochemical_Profile</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Bones" name="Bones">
        <Definition>Regular connective tissue, which consists of osteocytes and related cells, the intercellular matrix of which is ossified. Examples: woven bone, compact bone (tissue).</Definition>
        <Definition>hard form of connective tissue that constitutes the majority of the skeleton of most vertebrates; it consists of an organic component (the cells and matrix) and an inorganic, or mineral component; the matrix contains a framework of collagenous fibers and is impregnated with the mineral component, chiefly calcium phosphate and calcium carbonate, which imparts the quality of rigidity to bone.</Definition>
        <Definition>Calcified connective tissue that forms the skeletal components of the body. (NCI)</Definition>
        <Definition>The mineralized osseous tissue that gives rigidity to the bones and forms its honeycomb-like three-dimensional internal structure. (NCI)</Definition>
        <Definition>The entire physical structure of an organism. It is composed of anatomic systems, regions, cavities, and spaces. (NCI)</Definition>
        <Definition>Connective tissue that forms the skeletal components of the body.</Definition>
        <Definition>The entire physical structure of an organism. It is composed of anatomic systems, regions, cavities, and spaces.</Definition>
        <Definition>The mineralized osseous tissue that gives rigidity to the bones and forms its honeycomb-like three-dimensional internal structure.</Definition>
        <Definition>Regular connective tissue, which consists of osteocytes and related cells, the intercellular matrix of which is ossified. Examples: woven bone, lamellar bone.</Definition>
        <Definition>Organ with cavitated organ parts, which primarily consists of compact (cortical) and cancellous bone, which surround bone marrow cavities; together with other bones, cartilages and joints, it constitutes the skeletal system. Examples: femur, sternum, maxilla, vertebra, talus.</Definition>
        <SemanticType code="T031" name="Body Substance"/>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <SemanticType code="T017" name="Anatomical Structure"/>
        <SemanticType code="T024" name="Tissue"/>
        <SemanticType code="T022" name="Body System"/>
        <Source name="NMVB"/>
        <Term preferred="true">Bones</Term>
        <Term>Bone (tissue) structure (body structure)</Term>
        <Term>Skeletal bones</Term>
        <Term>Entire bone (organ) (body structure)</Term>
        <Term>Bone (organ)</Term>
        <Term>Ossa</Term>
        <Term>bones</Term>
        <Term>Bone (tissue) structure</Term>
        <Term>Set of bones</Term>
        <Term>Bones set</Term>
        <Term>Entire bony skeleton (body structure)</Term>
        <Term>Bone (system)</Term>
        <Term>Bone, NOS</Term>
        <Term>Entire bone (organ)</Term>
        <Term>bone tissue</Term>
        <Term>Body structure (body structure)</Term>
        <Term>Bony skeleton</Term>
        <Term>Skeleton system</Term>
        <Term>set of bones</Term>
        <Term>Body structure</Term>
        <Term>Skeletal bone</Term>
        <Term>Bone (tissue)</Term>
        <Term>BONE</Term>
        <Term>Osseous part of the skeletal system</Term>
        <Term>Tissues, Bone</Term>
        <Term>Tissue, Bone</Term>
        <Term>Bone Tissue</Term>
        <Term>bone</Term>
        <Term>Entire bony skeleton</Term>
        <Term>Bone</Term>
        <Term>Os</Term>
        <Term>Bone tissue</Term>
        <Term>Individual bone</Term>
        <Term>Bone organ</Term>
        <Term>bone organ</Term>
        <Term>Bone Tissues</Term>
        <Term>Specimen Type - Bone</Term>
        <Term>Osseous</Term>
        <Term>Body structures</Term>
        <Term>Bone structure (body structure)</Term>
        <Term>osseous tissue</Term>
        <Term>Bone structure</Term>
        <Term>Osseous Tissue</Term>
        <Term>skeletal bone</Term>
        <Term>Systema skeletale</Term>
        <Term>Bony tissue</Term>
        <Term>Pars ossea systematis skeletalis</Term>
        <Codes>
          <Code code="123037004" source="123037004"/>
          <Code code="C1266908" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Head_Neck" name="Head &amp; Neck">
        <Definition>Primary or metastatic malignant neoplasm affecting the head and neck. Representative examples include oral cavity squamous cell carcinoma, laryngeal squamous cell carcinoma, and salivary gland carcinoma. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=38961&amp;idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=38961&amp;idtype=1&amp;closed=1" closed clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&amp;code=C4013" NCI Thesaurus)</Definition>
        <Definition>A primary or metastatic malignant neoplasm affecting the head and neck. Representative examples include oral cavity squamous cell carcinoma, laryngeal squamous cell carcinoma, and salivary gland carcinoma.</Definition>
        <Definition>Cancer that arises in the head or neck region (in the nasal cavity, sinuses, lip, mouth, salivary glands, throat, or larynx [voice box]).</Definition>
        <Definition>CTEP_For_FDA: 90002024/Head and Neck</Definition>
        <Definition>&lt;p&gt;Head and neck cancer includes cancers of the &lt;a href='http://www.nlm.nih.gov/medlineplus/oralcancer.html'&gt;mouth&lt;/a&gt;, &lt;a href='http://www.nlm.nih.gov/medlineplus/nasalcancer.html'&gt;nose&lt;/a&gt;, sinuses, &lt;a href='http://www.nlm.nih.gov/medlineplus/salivaryglandcancer.html'&gt;salivary glands&lt;/a&gt;, &lt;a href='http://www.nlm.nih.gov/medlineplus/throatcancer.html'&gt;throat&lt;/a&gt;, and lymph nodes in the neck. Most begin in the moist tissues that line the mouth, nose and throat. Symptoms include&lt;/p&gt;&lt;ul&gt;&lt;li&gt; A lump or sore that does not heal&lt;/li&gt;&lt;li&gt; A sore throat that does not go away&lt;/li&gt;&lt;li&gt; Trouble swallowing&lt;/li&gt;&lt;li&gt; A change or hoarseness in the voice&lt;/li&gt; &lt;/ul&gt;&lt;p&gt;Using tobacco or alcohol increases your risk. In fact, 85 percent of head and neck cancers are linked to tobacco use, including &lt;a href='http://www.nlm.nih.gov/medlineplus/smoking.html'&gt;smoking&lt;/a&gt; and &lt;a href='http://www.nlm.nih.gov/medlineplus/smokelesstobacco.html'&gt;smokeless tobacco&lt;/a&gt;. If found early, these cancers are often curable. Treatments may include surgery, radiation therapy, chemotherapy or a combination. Treatments can affect eating, speaking or even breathing, so patients may need rehabilitation.&lt;/p&gt;&lt;p &gt;NIH: National Cancer Institute&lt;/p&gt;</Definition>
        <SemanticType code="T191" name="Neoplastic Process"/>
        <Source name="NMVB"/>
        <Term preferred="true">Head &amp; Neck</Term>
        <Term>Malignant tumor of head and/or neck</Term>
        <Term>Malignant tumour of head and/or neck</Term>
        <Term>Malignant tumour of head and neck</Term>
        <Term>Malignant tumor of head and neck</Term>
        <Term>Malignant tumor of head and/or neck (disorder)</Term>
        <Codes>
          <Code code="C0278996" source="C0278996"/>
          <Code code="255056009" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Changes_of_talc_pleurodesis" name="Changes of talc pleurodesis">
        <SemanticType code="T061" name="Therapeutic or Preventive Procedure"/>
        <Source name="NMVB"/>
        <Term preferred="true">Changes of talc pleurodesis</Term>
        <Term>Talc pleurodesis (procedure)</Term>
        <Term>Talc pleurodesis</Term>
        <Codes>
          <Code code="302450005" source="302450005"/>
          <Code code="C0405997" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Additional_Pathologic_Findings</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Tumor_Dimension" name="Tumor Dimension">
        <Source name="NMVB"/>
        <Term preferred="true">Tumor Dimension</Term>
        <Relations>
          <Relation name="Broader">NMVB:Terminology</Relation>
          <Relation name="Narrower">NMVB:3D_tumor_size</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Tumor_Site_Slot" name="Tumor Site Slot">
        <Source name="NMVB"/>
        <Term preferred="true">Tumor Site Slot</Term>
        <Relations>
          <Relation name="Broader">NMVB:Slot</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Indeterminate" name="Indeterminate">
        <Definition>Cannot distinguish between two or more possible values in the current context.</Definition>
        <Definition>Cannot distinguish between two or more possible values in the current context. (NCI)</Definition>
        <Definition>&lt;p&gt;&lt;b&gt;Description:&lt;/b&gt; The value of this observation does not allow interpretation as to whether or not the analyte or sign in question is present.&lt;/p&gt;</Definition>
        <Definition>&lt;p&gt;&lt;b&gt;Description:&lt;/b&gt;The conformance expectations for this element have not yet been determined.&lt;/p&gt;</Definition>
        <SemanticType code="T034" name="Laboratory or Test Result"/>
        <SemanticType code="T080" name="Qualitative Concept"/>
        <Source name="NMVB"/>
        <Term preferred="true">Indeterminate</Term>
        <Term>indeterminate</Term>
        <Term>Undetermined</Term>
        <Term>Unable to Determine</Term>
        <Term>INDETERMINATE</Term>
        <Term>Undetermined (qualifier value)</Term>
        <Term>Cannot Be Determined</Term>
        <Term>Grade cannot be determined (finding)</Term>
        <Term>Inconclusive</Term>
        <Term>undetermined</Term>
        <Term>unable to determine</Term>
        <Term>Indeterminate (qualifier value)</Term>
        <Term>Grade cannot be determined</Term>
        <Codes>
          <Code code="C0205258" source="C0205258"/>
          <Code code="384741006" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Differentiation_or_Grade</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Surgical_Margins" name="Surgical Margins">
        <Definition>One of the criteria for assessment of the effectiveness of given surgical procedure in achieving the local control of a neoplasm and the adequacy of tumor removal. It is defined by the tissue plane through which the dissection has been done and the actual or potential neoplastic tissue which has been left outside the boundary of a resected specimen within the patient. There are four types of surgical margins: intracapsular or intralesional, marginal, wide, and radical.</Definition>
        <Definition>The edge or border of the tissue removed in cancer surgery. The margin is described as negative or clean when the pathologist finds no cancer cells at the edge of the tissue, suggesting that all of the cancer has been removed. The margin is described as positive or involved when the pathologist finds cancer cells at the edge of the tissue, suggesting that all of the cancer has not been removed.</Definition>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <Source name="NMVB"/>
        <Term preferred="true">Surgical Margins</Term>
        <Term>margin</Term>
        <Term>Surgical Margin</Term>
        <Term>Surgical margins</Term>
        <Term>Margins of excision</Term>
        <Term>Surgical margins (body structure)</Term>
        <Codes>
          <Code code="C0229985" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Terminology</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Histochemical_Special_Stain_Profile_Slot" name="Histochemical Special Stain Profile Slot">
        <Source name="NMVB"/>
        <Term preferred="true">Histochemical Special Stain Profile Slot</Term>
        <Relations>
          <Relation name="Broader">NMVB:Slot</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:HBME-1" name="HBME-1">
        <Source name="NMVB"/>
        <Term preferred="true">HBME-1</Term>
        <Relations>
          <Relation name="Broader">NMVB:Immunohistochemical_Profile</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:TAG-72" name="TAG-72">
        <Source name="NMVB"/>
        <Term preferred="true">TAG-72</Term>
        <Relations>
          <Relation name="Broader">NMVB:Immunohistochemical_Profile</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Brain_CNS" name="Brain &amp; CNS">
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <Source name="NMVB"/>
        <Term preferred="true">Brain &amp; CNS</Term>
        <Term>Entire brain and spinal cord (body structure)</Term>
        <Term>Entire brain and spinal cord</Term>
        <Codes>
          <Code code="C1300324" source="C1300324"/>
          <Code code="389111004" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Cystic" name="Cystic">
        <SemanticType code="T033" name="Finding"/>
        <SemanticType code="T080" name="Qualitative Concept"/>
        <Source name="NMVB"/>
        <Term preferred="true">Cystic</Term>
        <Term>Cystic tumor configuration</Term>
        <Term>Cystic (qualifier value)</Term>
        <Term>Cystic tumour configuration</Term>
        <Term>Cystic tumor configuration (finding)</Term>
        <Term>cystic</Term>
        <Codes>
          <Code code="369746007" source="369746007"/>
          <Code code="C0205207" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Configuration</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:CD31" name="CD31">
        <Definition>Cell adhesion molecules present on virtually all monocytes, platelets, and granulocytes. CD31 is highly expressed on endothelial cells and concentrated at the junctions between them.</Definition>
        <Definition>CD31 antigen (738 aa, 83 kD) is a cell communication protein that is encoded by the human PECAM1 gene and has a role in cell recognition and signal transduction.</Definition>
        <Definition>Human HBA1 wild-type allele is located in the vicinity of 16p13.3 and is approximately 1 kb in length. This allele, which encodes hemoglobin subunit alpha protein, plays a role in the regulation of vascular oxygen transport. Mutation or deletion of the gene is associated with alpha-thalassemia.</Definition>
        <Definition>This gene is involved in several cellular processes such as: thrombosis, hemostasis, immunity, and inflammatory responses.</Definition>
        <Definition>Human PECAM1 wild-type allele is located within 17q23 and is approximately 64 kb in length. This allele, which encodes platelet endothelial cell adhesion molecule protein, plays a role in transendothelial migration of leukocytes, angiogenesis, integrin activation, and may inhibit platelet-collagen interactions.</Definition>
        <SemanticType code="T028" name="Gene or Genome"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="NMVB"/>
        <Term preferred="true">CD31</Term>
        <Term>PECAM1 Gene</Term>
        <Term>Antigens, CD31 [Chemical/Ingredient]</Term>
        <Term>PLATELET-ENDOTHELIAL CELL ADHESION MOLECULE 1</Term>
        <Term>Hemoglobin Alpha-1 Chain Gene</Term>
        <Term>PECAM1 gene</Term>
        <Term>CD 031 ANTIGENS</Term>
        <Term>Alpha-1 Globin Gene</Term>
        <Term>PECAM1 wt Allele</Term>
        <Term>Antigens, CD31</Term>
        <Term>Platelet Endothelial Cell Adhesion Molecule 1</Term>
        <Term>Cluster of differentiation antigen 31</Term>
        <Term>HBA1 wt Allele</Term>
        <Term>CD31 - Cluster of differentiation antigen 31</Term>
        <Term>PLATELET ENDOTHELIAL CELL ADHESION MOLECULE 001</Term>
        <Term>PECAM 001</Term>
        <Term>Hemoglobin, Alpha 1 wt Allele</Term>
        <Term>Antigen, CD31</Term>
        <Term>Platelet Endothelial Cell Adhesion Molecule-1</Term>
        <Term>platelet/endothelial cell adhesion molecule 1</Term>
        <Term>Hemoglobin Alpha 1 Globin Chain Gene</Term>
        <Term>(gDNA).PECAM1</Term>
        <Term>Alpha One Globin Gene</Term>
        <Term>PECAM-1 - Platelet endothelial cell adhesion molecule-1</Term>
        <Term>MGC126895</Term>
        <Term>HBH</Term>
        <Term>Platelet Endothelial Cell Adhesion Molecule</Term>
        <Term>Platelet/Endothelial Cell Adhesion Molecule (CD31 Antigen) Gene</Term>
        <Term>platelet/endothelial cell adhesion molecule (CD31 antigen)</Term>
        <Term>Platelet/Endothelial Cell Adhesion Molecule (CD31 Antigen) wt Allele</Term>
        <Term>PECAM-1</Term>
        <Term>ANTIGENS CD 031</Term>
        <Term>PECAM1</Term>
        <Term>CD31 Antigen</Term>
        <Term>Lymphocyte antigen CD31 (substance)</Term>
        <Term>MGC126897</Term>
        <Term>Lymphocyte antigen CD31</Term>
        <Term>CD31 Ag</Term>
        <Term>Platelet endothelial cell adhesion molecule-1</Term>
        <Term>CD31 antigen</Term>
        <Term>EndoCAM</Term>
        <Term>Alpha-1-Globin Gene</Term>
        <Term>CD31 Antigens</Term>
        <Term>GPIIA'</Term>
        <Codes>
          <Code code="C1706508" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Immunohistochemical_Profile</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Ferruginous_bodies" name="Ferruginous bodies">
        <SemanticType code="T046" name="Pathologic Function"/>
        <Source name="NMVB"/>
        <Term preferred="true">Ferruginous bodies</Term>
        <Term>Ferruginous body (morphologic abnormality)</Term>
        <Term>Ferruginous body</Term>
        <Codes>
          <Code code="C1301345" source="C1301345"/>
          <Code code="397325001" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Additional_Pathologic_Findings</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:left_pleura" name="left pleura">
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <Source name="NMVB"/>
        <Term preferred="true">left pleura</Term>
        <Term>Membrane of left pleural sac</Term>
        <Term>Entire left pleura (body structure)</Term>
        <Term>Left pleura structure (body structure)</Term>
        <Term>Left pleura</Term>
        <Term>Left pleural sac membrane</Term>
        <Term>Left pleura structure</Term>
        <Term>Entire left pleura</Term>
        <Codes>
          <Code code="362001001" source="362001001"/>
          <Code code="C1183943" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Adrenal" name="Adrenal">
        <Definition>active sympathomimetic hormone from the adrenal medulla in most species; it stimulates both the alpha- and beta- adrenergic systems, causes systemic vasoconstriction and gastrointestinal relaxation, stimulates the heart, and dilates bronchi and cerebral vessels; used in treatment of asthma and cardiac failure and to delay absorption of local anesthetics.</Definition>
        <Definition>The synthetic form of the naturally occurring sympathomimetic amine with vasoconstricting, intraocular pressure-reducing, and bronchodilating activities. By stimulating vascular alpha-adrenergic receptors, epinephrine causes vasoconstriction, thereby increasing vascular resistance and blood pressure. When administered in the conjunctiva, this agent binds to alpha-adrenergic receptors in the iris sphincter muscle, resulting in vasoconstriction, a decrease in the production of aqueous humor, and a lowering of intraocular pressure. Through its beta1 receptor-stimulating actions, epinephrine increases the force and rate of myocardial contraction and relaxes bronchial smooth muscle, resulting in bronchodilation. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=41857&amp;idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=41857&amp;idtype=1&amp;closed=1" closed clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&amp;code=C473" NCI Thesaurus)</Definition>
        <Definition>The active sympathomimetic hormone from the ADRENAL MEDULLA. It stimulates both the alpha- and beta- adrenergic systems, causes systemic VASOCONSTRICTION and gastrointestinal relaxation, stimulates the HEART, and dilates BRONCHI and cerebral vessels. It is used in ASTHMA and CARDIAC FAILURE and to delay absorption of local ANESTHETICS.</Definition>
        <Definition>The synthetic form of the naturally occurring sympathomimetic amine with vasoconstricting, intraocular pressure-reducing, and bronchodilating activities. By stimulating vascular alpha-adrenergic receptors, epinephrine causes vasoconstriction, thereby increasing vascular resistance and blood pressure. When administered in the conjunctiva, this agent binds to alpha-adrenergic receptors in the iris sphincter muscle, resulting in vasoconstriction, a decrease in the production of aqueous humor, and a lowering of intraocular pressure. Through its beta1 receptor-stimulating actions, epinephrine increases the force and rate of myocardial contraction and relaxes bronchial smooth muscle, resulting in bronchodilation.</Definition>
        <SemanticType code="T109" name="Organic Chemical"/>
        <SemanticType code="T125" name="Hormone"/>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <SemanticType code="T033" name="Finding"/>
        <SemanticType code="T121" name="Pharmacologic Substance"/>
        <Source name="NMVB"/>
        <Term preferred="true">Adrenal</Term>
        <Term>Adrenal part (body structure)</Term>
        <Term>Epinephrine</Term>
        <Term>Epinephrine (substance)</Term>
        <Term>4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol</Term>
        <Term>Epinephrine [Chemical/Ingredient]</Term>
        <Term>Adrenal hormone agent (substance)</Term>
        <Term>Adrenal hormone</Term>
        <Term>Adrenal hormone agent</Term>
        <Term>Epinephrine product</Term>
        <Term>epinephrine</Term>
        <Term>Adrenaline product</Term>
        <Term>Adrenaline</Term>
        <Term>adrenaline</Term>
        <Term>Corticosteroid preparation</Term>
        <Term>Adrenal part</Term>
        <Term>epi</Term>
        <Term>Adrenal hormone preparation (product)</Term>
        <Term>Epi</Term>
        <Term>EPINEPHRINE</Term>
        <Term>Epinephrine preparation (product)</Term>
        <Term>Therapeutic Epinephrine</Term>
        <Term>therapeutic epinephrine</Term>
        <Term>Adrenal hormone preparation</Term>
        <Term>EPINEPHrine</Term>
        <Term>Adrenalin</Term>
        <Term>Epinephrine preparation</Term>
        <Term>adrenalin</Term>
        <Term>Adrenal hormone (substance)</Term>
        <Term>1,2-Benzenediol, 4-(1-hydroxy-2-(methylamino)ethyl)-, (R)-</Term>
        <Term>Adrenaline preparation</Term>
        <Codes>
          <Code code="C1445654" source="Code"/>
          <Code code="362894002" source="362894002"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:acute_inflammation" name="acute inflammation">
        <Definition>A morphologic finding indicating the presence of neutrophils and/or eosinophils in a tissue sample.</Definition>
        <SemanticType code="T033" name="Finding"/>
        <Source name="NMVB"/>
        <Term preferred="true">acute inflammation</Term>
        <Term>Acute inflammatory cell infiltration</Term>
        <Term>Polymorphonuclear leucocyte infiltration</Term>
        <Term>Neutrophilic infiltration</Term>
        <Term>Acute inflammation</Term>
        <Term>Active inflammation</Term>
        <Term>Acute inflammatory reaction</Term>
        <Term>Acute inflammation (morphologic abnormality)</Term>
        <Term>Acute inflammatory infiltration</Term>
        <Term>Polymorphonuclear leukocyte infiltration</Term>
        <Term>Acute Inflammatory Infiltrate</Term>
        <Codes>
          <Code code="C0333361" source="C0333361"/>
          <Code code="4532008" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Additional_Pathologic_Findings</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Multicystic_mesothelioma" name="Multicystic mesothelioma">
        <Definition>An intermediate grade neoplasm arising from mesothelial cells. It occurs in the peritoneum, extraperitoneal space, omentum, or pelvic or abdominal viscera. It is characterized by the presence of multiple cysts lined by flattened or cuboidal mesothelial cells. There is no evidence of significant cytologic atypia or increased mitotic activity. It usually occurs in young to middle-aged women. Patients present with abdominal or pelvic mass and pain. Approximately half of the cases recur. The recurrences may appear several years after the initial diagnosis. Rare cases of transformation to malignant mesothelioma have also been described.</Definition>
        <Definition>A peritoneal mesothelioma affecting mainly young females and producing cysts of variable size and number lined by a single layer of benign mesothelial cells. The disease follows a benign course and is compatible with a normal life expectancy, requiring occasionally partial excision or decompression for relief of pain or other symptoms. Malignant potential is exceptional. (From Holland et al., Cancer Medicine, 3d ed, p1345)</Definition>
        <SemanticType code="T191" name="Neoplastic Process"/>
        <Source name="NMVB"/>
        <Term preferred="true">Multicystic mesothelioma</Term>
        <Term>Cystic mesothelioma (morphologic abnormality)</Term>
        <Term>Multicystic Mesothelioma</Term>
        <Term>Cystic Mesothelioma</Term>
        <Term>Mesotheliomas, Cystic</Term>
        <Term>Multicystic mesothelioma, benign</Term>
        <Term>Intermediate Mesothelioma</Term>
        <Term>Cystic mesothelioma</Term>
        <Term>Cystic mesothelioma, benign</Term>
        <Term>Mesothelioma, Cystic</Term>
        <Term>Cystic Mesotheliomas</Term>
        <Term>Multicystic mesothelioma, benign (morphologic abnormality)</Term>
        <Term>Mesothelioma, Cystic [Disease/Finding]</Term>
        <Term>Cystic mesothelioma, NOS</Term>
        <Codes>
          <Code code="C0206680" source="C0206680"/>
          <Code code="128901009" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Histological_Type</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Nodular" name="Nodular">
        <SemanticType code="T080" name="Qualitative Concept"/>
        <Source name="NMVB"/>
        <Term preferred="true">Nodular</Term>
        <Term>Nodular (qualifier value)</Term>
        <Term>nodular</Term>
        <Codes>
          <Code code="255288007" source="Code"/>
          <Code code="C0205297" source="C0205297"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Configuration</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Calretinin" name="Calretinin">
        <Definition>A calbindin protein that is differentially expressed in distinct populations of NEURONS throughout the vertebrate and invertebrate NERVOUS SYSTEM, and modulates intrinsic neuronal excitability and influences LONG-TERM POTENTIATION. It is also found in LUNG, TESTIS, OVARY, KIDNEY, and BREAST, and is expressed in many tumor types found in these tissues. It is often used as an immunohistochemical marker for MESOTHELIOMA.</Definition>
        <Definition>calcium binding protein that is found in subpopulations of cortical and subcortical brain neurons with a molecular weight of 29,000 daltons.</Definition>
        <SemanticType code="T028" name="Gene or Genome"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="NMVB"/>
        <Term preferred="true">Calretinin</Term>
        <Term>calbindin 2</Term>
        <Term>CALB2 gene</Term>
        <Term>CALB2</Term>
        <Term>CAL2</Term>
        <Term>CALBINDIN D29K</Term>
        <Term>CALBINDIN, 29-KD</Term>
        <Term>Calbindin 2 [Chemical/Ingredient]</Term>
        <Term>CALRETININ</Term>
        <Term>CALBINDIN 2</Term>
        <Term>calretinin</Term>
        <Term>Calbindin 2</Term>
        <Codes>
          <Code code="C1413081" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Immunohistochemical_Profile</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Configuration" name="Configuration">
        <Definition>The spatial property of the way in which something is placed.</Definition>
        <Definition>Refers to 1) the way a computer's operating system is set up, 2) the total combination of hardware components that make up the computer system, or 3) the specific software settings that have been established for the system.</Definition>
        <SemanticType code="T082" name="Spatial Concept"/>
        <SemanticType code="T077" name="Conceptual Entity"/>
        <Source name="NMVB"/>
        <Term preferred="true">Configuration</Term>
        <Term>Arrangement</Term>
        <Term>Computer Configuration</Term>
        <Term>Config</Term>
        <Term>With configuration</Term>
        <Term>Has configuration</Term>
        <Term>With configuration (attribute)</Term>
        <Codes>
          <Code code="C2827597" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Attributes</Relation>
          <Relation name="Narrower">NMVB:Cystic, NMVB:Mixed, NMVB:Exophytic, NMVB:Nodular, NMVB:Diffuse, NMVB:Endophytic, NMVB:Localized, NMVB:Papillary</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Differentiation_or_Grade" name="Differentiation or Grade">
        <Source name="NMVB"/>
        <Term preferred="true">Differentiation or Grade</Term>
        <Relations>
          <Relation name="Broader">NMVB:Attributes</Relation>
          <Relation name="Narrower">NMVB:Low, NMVB:Intermediate, NMVB:High, NMVB:Indeterminate</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Urinary_Bladder" name="Urinary Bladder">
        <Definition>The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra.</Definition>
        <Definition>A musculomembranous sac along the URINARY TRACT. URINE flows from the KIDNEYS into the bladder via the ureters (URETER), and is held there until URINATION.</Definition>
        <Definition>musculomembranous sac in the anterior of the pelvic cavity that serves as a reservoir for urine, which it receives through the ureters and discharges through the urethra.</Definition>
        <Definition>The tissue that forms the bladder wall. It consists of mucosa, muscular coat, and serosal surface. (NCI)</Definition>
        <Definition>Organ with organ cavity which is continuous proximally with the right and left ureters and distally with the urethra. Examples: There is only one urinary bladder.</Definition>
        <Definition>A primary or metastatic malignant neoplasm involving the bladder.</Definition>
        <Definition>The tissue that forms the bladder wall. It consists of mucosa, muscular coat, and serosal surface.</Definition>
        <Definition>&lt;p&gt;The bladder is a hollow organ in your lower abdomen that stores urine. Bladder cancer occurs in the lining of the bladder. It is the sixth most common type of cancer in the United States.&lt;/p&gt;&lt;p&gt;Symptoms include&lt;/p&gt;&lt;ul&gt; &lt;li&gt;Blood in your urine&lt;/li&gt; &lt;li&gt;A frequent urge to urinate&lt;/li&gt; &lt;li&gt;Pain when you urinate&lt;/li&gt; &lt;li&gt;Low back pain&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;Risk factors for developing bladder cancer include smoking and exposure to certain chemicals in the workplace. People with a family history of bladder cancer or who are older, white, or male have a higher risk.&lt;/p&gt;&lt;p&gt;Treatments for bladder cancer include surgery, radiation therapy, chemotherapy, and biologic therapy. Biologic therapy boosts your body's own ability to fight cancer.&lt;/p&gt;&lt;p &gt;NIH: National Cancer Institute&lt;/p&gt;</Definition>
        <Definition>The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra. (NCI)</Definition>
        <Definition>The organ that stores urine.</Definition>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <SemanticType code="T191" name="Neoplastic Process"/>
        <SemanticType code="T024" name="Tissue"/>
        <Source name="NMVB"/>
        <Term preferred="true">Urinary Bladder</Term>
        <Term>Urinary bladder structure (body structure)</Term>
        <Term>Vesica urinaria</Term>
        <Term>bladder</Term>
        <Term>Bladder, NOS</Term>
        <Term>URINARY BLADDER</Term>
        <Term>Bladder, Urinary</Term>
        <Term>Malignant tumor of urinary bladder (disorder)</Term>
        <Term>Bladder Tissue</Term>
        <Term>urinary bladder</Term>
        <Term>Malignant tumor of urinary bladder</Term>
        <Term>Bladder</Term>
        <Term>Malignant tumour of urinary bladder</Term>
        <Term>CA - Bladder cancer</Term>
        <Term>Urinary bladder</Term>
        <Term>BLADDER</Term>
        <Term>Urinary System, Bladder</Term>
        <Term>Malignant neoplasm of urinary bladder</Term>
        <Term>Urinary bladder, NOS</Term>
        <Term>Urinary bladder structure</Term>
        <Term>Bladder cancer</Term>
        <Term>Bladder structure</Term>
        <Term>Bladder wall, NOS</Term>
        <Codes>
          <Code code="399326009" source="399326009"/>
          <Code code="C1511200" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Oral_Cavity" name="Oral Cavity">
        <Definition>The cavity located at the upper end of the alimentary canal, behind the teeth and gums that is bounded on the outside by the lips, above by the hard and soft palates and below by the tongue.</Definition>
        <Definition>Refers to the mouth. It includes the lips, the lining inside the cheeks and lips, the front two thirds of the tongue, the upper and lower gums, the floor of the mouth under the tongue, the bony roof of the mouth, and the small area behind the wisdom teeth.</Definition>
        <Definition>A primary or metastatic malignant neoplasm involving the oral cavity. The majority are squamous cell carcinomas.</Definition>
        <Definition>The oval-shaped oral cavity located at the apex of the digestive tract and consisting of two parts: the vestibule and the oral cavity proper.</Definition>
        <Definition>The cavity located at the upper end of the alimentary canal, behind the teeth and gums that is bounded on the outside by the lips, above by the hard and soft palates and below by the tongue. (NCI)</Definition>
        <Definition>The oval-shaped oral cavity located at the apex of the digestive tract and consisting of two parts: the vestibule and the oral cavity proper. [MeSH]</Definition>
        <Definition>oval shaped oral cavity located at the apex of the digestive tract.</Definition>
        <SemanticType code="T030" name="Body Space or Junction"/>
        <SemanticType code="T191" name="Neoplastic Process"/>
        <SemanticType code="T029" name="Body Location or Region"/>
        <Source name="NMVB"/>
        <Term preferred="true">Oral Cavity</Term>
        <Term>Malignant tumor of oral cavity</Term>
        <Term>BODY CAVITY, ORAL</Term>
        <Term>Entire oral cavity</Term>
        <Term>Cancer of oral cavity</Term>
        <Term>Malignant tumour of oral cavity</Term>
        <Term>Mouth</Term>
        <Term>Orally</Term>
        <Term>Cavitas Oris</Term>
        <Term>Malignant tumour of mouth</Term>
        <Term>Cavity, Oral</Term>
        <Term>ORAL CAVITY</Term>
        <Term>cavity of mouth</Term>
        <Term>Malignant tumor of oral cavity (disorder)</Term>
        <Term>oral cavity</Term>
        <Term>Oral cavity structure (body structure)</Term>
        <Term>Buccal Cavity</Term>
        <Term>CA - Mouth cancer</Term>
        <Term>Malignant tumor of mouth</Term>
        <Term>Oral cavity structure</Term>
        <Term>Malignant neoplasm of mouth</Term>
        <Term>Cavity of mouth</Term>
        <Term>oral cav</Term>
        <Term>Oral</Term>
        <Term>Buccal cavity</Term>
        <Term>Mouth cancer</Term>
        <Term>Entire oral cavity (body structure)</Term>
        <Term>Cavitas oris</Term>
        <Term>Oral cavity</Term>
        <Term>Mouth, NOS</Term>
        <Term>mouth</Term>
        <Codes>
          <Code code="363505006" source="363505006"/>
          <Code code="C1278910" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:E-cadherin" name="E-cadherin">
        <Source name="NMVB"/>
        <Term preferred="true">E-cadherin</Term>
        <Relations>
          <Relation name="Broader">NMVB:Immunohistochemical_Profile</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Slot" name="slot">
        <Source name="NMVB"/>
        <Term preferred="true">slot</Term>
        <Relations>
          <Relation name="Broader">owl:Thing</Relation>
          <Relation name="Narrower">NMVB:Histological_Type_Slot, NMVB:Immunohistochemical_Profile_Slot, NMVB:Additional_Pathologic_Findings_Slot, NMVB:Surgical_Margins_Slot, NMVB:Histochemical_Special_Stain_Profile_Slot, NMVB:Tumor_Slot, NMVB:Tumor_Site_Slot, NMVB:Tumor_Dimension_Slot</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Intermediate" name="Intermediate">
        <Definition>An index used in neuroblastic tumors indicating the presence of between 100 and 200 mitoses and karyorrhexis per 5,000 cells.</Definition>
        <Definition>Lying between two extremes in time or space or degree. (WordNet)</Definition>
        <Definition>Mid-way between small and large in number, quantity, magnitude or extent.</Definition>
        <Definition>A microbial susceptibility test result in which the growth of microorganisms may be inhibited by the usually achievable concentrations of antimicrobial agent when the recommended dosage is used for the site of infection. The response rates may be lower than for susceptible isolates.</Definition>
        <Definition>The growth of microorganisms may be inhibited by antimicrobials that approach usually attainable blood and tissue concentrations. The response rates may be lower than for susceptible isolates. This category also includes a buffer zone, which should prevent small, uncontrolled, technical factors from causing major discrepancies in interpretations, especially for drugs with narrow pharmacotoxicity margins.</Definition>
        <Definition>Located between two points or extremes.</Definition>
        <Definition>Mid-way between small and large in number, quantity, magnitude or extent. (NCI)</Definition>
        <Definition>&lt;p&gt;Intermediate&lt;/p&gt;</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <SemanticType code="T033" name="Finding"/>
        <SemanticType code="T034" name="Laboratory or Test Result"/>
        <SemanticType code="T080" name="Qualitative Concept"/>
        <SemanticType code="T081" name="Quantitative Concept"/>
        <Source name="NMVB"/>
        <Term preferred="true">Intermediate</Term>
        <Term>Moderately differentiated histological grade finding</Term>
        <Term>INTERMEDIATE</Term>
        <Term>MEDIUM</Term>
        <Term>Medium</Term>
        <Term>In between</Term>
        <Term>Intermediate (qualifier value)</Term>
        <Term>intermediate</Term>
        <Term>medium</Term>
        <Term>Between</Term>
        <Term>Intermediate Mitosis-Karyorrhexis Index</Term>
        <Term>Antimicrobial Intermediate Susceptibility Result</Term>
        <Term>Observation Interpretation - intermediate</Term>
        <Term>Medium (qualifier value)</Term>
        <Term>Moderately differentiated histological grade finding (finding)</Term>
        <Term>Inter-</Term>
        <Codes>
          <Code code="CL480874" source="CL480874"/>
          <Code code="373377004" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Differentiation_or_Grade</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:CK7" name="CK7">
        <Definition>Human KRT7 wild-type allele is located within 12q12-q13 and is approximately 16 kb in length. This allele, which encodes keratin, type II cytoskeletal 7 protein, is involved in the regulation of DNA replication.</Definition>
        <Definition>This gene plays a role in DNA replication.</Definition>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="NMVB"/>
        <Term preferred="true">CK7</Term>
        <Term>MGC129731</Term>
        <Term>cytokeratin 7</Term>
        <Term>K7</Term>
        <Term>sarcolectin</Term>
        <Term>K2C7</Term>
        <Term>Keratin, 55K Type II Cytoskeletal Gene</Term>
        <Term>SCL</Term>
        <Term>Keratin 7 Gene</Term>
        <Term>keratin, type II cytoskeletal 7</Term>
        <Term>SARCOLECTIN</Term>
        <Term>Type II Mesothelial Keratin K7 Gene</Term>
        <Term>KRT7 wt Allele</Term>
        <Term>KERATIN, TYPE II, CYTOSKELETAL, 7</Term>
        <Term>MGC3625</Term>
        <Term>keratin, 55K type II cytoskeletal</Term>
        <Term>KRT7</Term>
        <Term>KERATIN, SIMPLE EPITHELIAL</Term>
        <Term>keratin 7</Term>
        <Term>Keratin, Simple Epithelial Type II, K7 Gene</Term>
        <Term>KRT7 gene</Term>
        <Term>KERATIN 7</Term>
        <Term>Keratin 7 wt Allele</Term>
        <Term>KRT7 Gene</Term>
        <Codes>
          <Code code="C3272782" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Immunohistochemical_Profile</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Lymph_node" name="Lymph node">
        <Source name="NMVB"/>
        <Term preferred="true">Lymph node</Term>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Pancreatic" name="Pancreatic">
        <Definition>Of or pertaining to the pancreas.</Definition>
        <Definition>&lt;p&gt;The pancreas is a gland behind your stomach and in front of your spine. It produces the juices that help break down food and the hormones that help control &lt;a href='http://www.nlm.nih.gov/medlineplus/bloodsugar.html'&gt;blood sugar&lt;/a&gt; levels. Pancreatic cancer usually begins in the cells that produce the juices. Some risk factors for developing pancreatic cancer include&lt;/p&gt;&lt;ul&gt;&lt;li&gt; Smoking &lt;/li&gt; &lt;li&gt; Long-term diabetes &lt;/li&gt; &lt;li&gt; Chronic pancreatitis &lt;/li&gt; &lt;li&gt; Certain hereditary disorders &lt;/li&gt; &lt;/ul&gt;&lt;p&gt;Pancreatic cancer is hard to catch early. It doesn't cause symptoms right away. When you do get symptoms, they are often vague or you may not notice them. They include yellowing of the skin and eyes, pain in the abdomen and back, weight loss and fatigue. Also, because the pancreas is hidden behind other organs, health care providers cannot see or feel the tumors during routine exams. Doctors use a physical exam, blood tests, imaging tests, and a biopsy to diagnose it.&lt;/p&gt; &lt;p&gt;Because it is often found late and it spreads quickly, pancreatic cancer can be hard to treat. Possible treatments include surgery, radiation, chemotherapy, and targeted therapy. Targeted therapy uses substances that attack cancer cells without harming normal cells.&lt;/p&gt;&lt;p &gt;NIH: National Cancer Institute&lt;/p&gt;</Definition>
        <Definition>A primary or metastatic malignant tumor involving the pancreas. Representative examples include carcinoma and lymphoma. -- 2003</Definition>
        <Definition>Having to do with the pancreas.</Definition>
        <SemanticType code="T191" name="Neoplastic Process"/>
        <SemanticType code="T080" name="Qualitative Concept"/>
        <Source name="NMVB"/>
        <Term preferred="true">Pancreatic</Term>
        <Term>Malignant tumour of pancreas</Term>
        <Term>pancreatic</Term>
        <Term>Malignant tumor of pancreas</Term>
        <Term>Malignant tumor of pancreas (disorder)</Term>
        <Codes>
          <Code code="363418001" source="363418001"/>
          <Code code="CL053214" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
      <Concept code="NMVB:Appendix" name="Appendix">
        <Definition>&lt;p&gt;Refers to a document serving as an appendix in a collection of documents.&lt;/p&gt;</Definition>
        <Definition>A small, fingerlike pouch that sticks out from the cecum (the first part of the large intestine near the end of the small intestine).</Definition>
        <Definition>Organ with organ cavity which is continuous proximally with the cecum and distally terminates in the tip of the appendix. Examples: There is only one appendix. [FMA]</Definition>
        <Definition>Small tissue projection existing as a cecal diverticulum with a questionable history of vestigial versus specialized organ.</Definition>
        <Definition>Organ with organ cavity which is continuous proximally with the cecum and distally terminates in the tip of the appendix. Examples: There is only one appendix.</Definition>
        <Definition>Small tissue projection existing as a cecal diverticulum with a questionable history of vestigial versus specialized organ. (NCI)</Definition>
        <Definition>A worm-like blind tube extension from the CECUM.</Definition>
        <SemanticType code="T078" name="Idea or Concept"/>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <Source name="NMVB"/>
        <Term preferred="true">Appendix</Term>
        <Term>Vermiform appendix</Term>
        <Term>Entire appendix</Term>
        <Term>LARGE INTESTINE, APPENDIX</Term>
        <Term>Appendix structure</Term>
        <Term>appendix</Term>
        <Term>appendix - HTML link</Term>
        <Term>Entire appendix (body structure)</Term>
        <Term>vermiform appendix</Term>
        <Term>Vermiform Appendix</Term>
        <Term>Appendix structure (body structure)</Term>
        <Term>APPENDIX</Term>
        <Term>Appendix vermiformis</Term>
        <Term>Appendix, Vermiform</Term>
        <Codes>
          <Code code="C1269000" source="C1269000"/>
          <Code code="181255000" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">NMVB:Tumor_Site</Relation>
        </Relations>
      </Concept>
    </Concepts>
    <Options>
      <Option name="window.size" value="-1"/>
      <Option name="source.filter" value=""/>
      <Option name="ignore.digits" value="false"/>
      <Option name="ignore.acronyms" value="false"/>
      <Option name="semantic.type.filter" value=""/>
      <Option name="default.search.method" value="best-match"/>
      <Option name="ordered.mode" value="false"/>
      <Option name="ignore.small.words" value="true"/>
      <Option name="partial.match.theshold" value="0.5"/>
      <Option name="ignore.common.words" value="false"/>
      <Option name="ignore.used.words" value="true"/>
      <Option name="handle.possible.acronyms" value="true"/>
      <Option name="select.best.candidate" value="false"/>
      <Option name="maximum.word.gap" value="1"/>
      <Option name="overlap.mode" value="true"/>
      <Option name="partial.mode" value="false"/>
      <Option name="stem.words" value="true"/>
      <Option name="language.filter" value=""/>
      <Option name="max.words.in.term" value="10"/>
      <Option name="subsumption.mode" value="true"/>
      <Option name="contiguous.mode" value="false"/>
      <Option name="enable.search.cache" value="false"/>
      <Option name="score.concepts" value="true"/>
    </Options>
  </Terminology>
</Template>
